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Abstract 
 
 Rab4 is a member of the Rab superfamily of small GTPases. It is localized to 
the early sorting endosome and plays a role in regulating the transport from this 
compartment to the recycling and degradative pathways. In order to further our 
understanding of the role Rab4 plays in endocytosis, a yeast two-hybrid screen was 
performed to identify putative Rab4 effectors. A constitutively active mutant of Rab4, 
Rab4Q67L, when used as bait to screen a HeLa cDNA library, identified a novel 
80kDa protein that interacted with Rab4-GTP. This protein was called Rab Coupling 
Protein (RCP). 
 RCP interacts preferentially with the GTP-bound form of Rab4. Subsequent 
work demonstrated that RCP also interacts with Rab11, and that this interaction is not 
nucleotide-depenedent. RCP is predominantly membrane-bound and localised to the 
perinuclear recycling compartment. Expression of a truncation mutant of RCP, that 
contains the Rab binding domain, in HeLa cells, results in the formation of an 
extensive tubular network that can be labelled with transferrin. These tubules are 
derived from the recycling compartment since they are inaccessible to transferrin 
when the ligand is internalised at 18oC. The truncation mutant-induced morphology 
can be rescued by overexpression of active Rab11, but not active Rab4. This suggests 
that RCP functions between Rab4 and Rab11 in the receptor recycling pathway, and 
may act as a ‘molecular bridge’ between these two sequentially acting small GTPases. 
Quantitative assays demonstrated that overexpression of the truncation mutant results 
in a dramatic inhibition in the rate of receptor recycling. 
 Database analysis revealed that RCP belongs to a family of Rab interacting 
proteins, each characterised by a carboxy-terminal coiled-coil domain and an amino-
terminal phospholipid-binding domain. KIAA0941, an RCP homologue, interacts 
with Rab11, but not with Rab4. Overexpression of its Rab binding domain also results 
in a tubular network, however, this tubulation cannot be rescued by active Rab11. 
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The eukaryotic cell has evolved an intricate machinery to transport cargo. There 
are numerous directions in which such cargo has to be transported. In broad terms 
these directions include into, out of, and within, the cell. However, each of these 
transport pathways can be subdivided into a series of highly regulated steps. The 
necessity to maintain the integrity and specificity of the multitude of transport steps 
requires a highly dynamic, and elaborate, machinery. Cargo is transported to and from 
the plasma membrane, and between organelles, in membrane-bound vesicles. The 
integrity of these transport processes is preserved by large protein complexes, unique 
to each step, that are present on donor and target vesicles. The precise mechanism of 
even one of these steps is still not fully understood. However, many of the important 
components involved have been identified. Key among these are the SNARE proteins 
and the small GTPases. The SNARE proteins mediate the fusion of transport vesicles 
with their target membranes. Several families of small GTPase, belonging to the Ras 
superfamily of small G-proteins, are involved in regulating the transport of cargo 
around the cell. ADP-ribosylation factor (ARF) GTPases are involved in maintaining 
the integrity of organelles and in the process of intracellular traffic. Rab GTPases are 
localised to the cytoplasmic face of all organelles involved in intracellular transport, 
where they play important regulatory roles in all aspects of each transport route. A 
family of larger GTPases, the dynamins, have been implicated in a process known as 
budding, during which pits containing cargo form in the plasma membrane and 
ultimately pinch off into the cytoplasm, forming vesicles. 
Intracellular transport can be divided into two main pathways, the endocytic and 
secretory pathways. The secretory pathway comprises the endoplasmic reticulum 
(ER), the Golgi apparatus, the vacuole, and the vesicles that mediate transport 
between them.  A protein that enters the secretory pathway is destined to undergo one 
of several possible fates, depending on the sorting signal it carries. A secretory 
protein, after passing through the ER and Golgi, is packaged into a secretory vesicle 
that is transported to, and fuses with, the plasma membrane resulting in the release of 
the protein into the extracellular space. Other proteins, instead of being secreted, may 
possess sorting information that specifies transport to a specific intracellular location, 
such as the vacuole. Finally some proteins contain retention signals that result in their 
permanent localisation in an organelle of the secretory pathway. Such proteins 
provide catalytic activities necessary for the function of the organelle e.g. the 
mannosyltransferases that reside in the Golgi apparatus.   
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The endocytic pathway can be subdivided into clathrin-dependent and clathrin-
independent endocytosis. The clathrin-dependent pathway is the better understood of 
the two and is the focus of this thesis. The clathrin-independent mechanism of 
endocytosis was initially observed in a mammalian system where dynamin function 
was switched off. This resulted in the rapid reduction of both receptor-mediated and 
fluid-phase endocytosis. However, within an hour fluid uptake returned to normal 
while receptor uptake remained inhibited (Mellman, 1996). Since internalisation of 
fluid markers was restored, despite the downregulation of clathrin-dependent 
endocytosis, another pathway must exist that can partially compensate for the 
inhibition. Further work identified caveolae, plasma membrane pits lacking clathrin, 
as a possible means for fluid uptake. Caveolae are found at varying frequencies in 
different cell types. They are most prominent in adipocytes, fibroblasts, and muscle 
cells. They have a characteristic striated appearance due to the accumulation of the 
integral membrane protein, caveolin. Caveolae have been implicated in endocytosis, 
transcytosis, and molecular sorting. At the plasma membrane they also serve to 
compartmentalise and integrate a wide variety of signal transduction pathways.  
 
1.1 Receptor-Mediated Endocytosis 
 
Receptor-mediated endocytosis is a process by which molecules present in the 
extracellular medium bind to specific receptors, located on the cell surface, and are 
subsequently transported to predetermined intracellular compartments. Receptors on 
the plasma membrane when bound by their ligand cluster together in small 
indentations, or invaginations, on the plasma membrane. These invaginations become 
coated by clathrin, which forms a lattice around the pit that acts as a scaffold for the 
recruitment of adaptor proteins. The adaptor proteins recognise signal sequences 
present on the cytoplasmic domain of receptors destined for internalisation (Robinson 
and Bonifacino, 2001). Dynamin wraps around the neck of these pits, which grow 
deeper and deeper into the cytoplasm, and is involved in their fission, or “pinching 
off”, to form clathrin coated vesicles (CCVs) (Hinshaw, 2000). These newly formed 
CCVs are transported to the early/sorting endosomes (SE). The pH difference in the 
sorting endosome results in the dissociation of the ligand/receptor complex. The cargo 
is then transported along the late endocytic pathway, eventually ending up in the 
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lysosomes where it is broken down. Meanwhile, the receptor can be recycled directly 
back to the plasma membrane from the sorting endosome, along the fast recycling 
pathway, or it may enter the pericentriolar recycling compartment (RC), prior to 
transport back to the plasma membrane. This is termed the slow recycling pathway. In 
some cases, the receptor follows its cargo along the late endocytic pathway to be 
broken down in the lysosomes.  
The transferrin receptor (TfnR) is a classic example of a receptor that follows 
the recycling pathway. It is a constitutively endocytosed receptor, i.e. it is 
endocytosed whether or not it is bound by its ligand (Willingham and Pastan, 1985). 
On the cell surface it can be bound by its ligand, iron-saturated transferrin (Tfn). The 
receptor is brought into the cell in CCVs, the iron dissociates in the SE and is 
transported to the lysosomes via the late endosome (LE). Meanwhile, the Tfn/TfnR 
complex is recycled back to the plasma membrane via the recycling compartment 
(Dautry-Varsat, 1986). The internalisation signal on the transferrin receptor is 
constitutively accessible to the adaptor complexes. In contrast, the epidermal growth 
factor (EGF) receptor carries a ‘cryptic’ internalisation signal that only becomes 
accessible to adaptors when it is bound by its ligand. Upon ligand binding, the EGF 
receptor undergoes tyrosine kinase activation, and autophosphorylation, that results in 
a structural change of the receptor’s cytoplasmic domain, exposing the internalisation 
signals. When internalised the EGF receptor follows a different pathway to the 
transferrin receptor.  At least 50% of the EGF receptor, when bound by EGF, is 
transported to the lysosomes for degradation, via the sorting and late endosomes (see 
Figure 2) (Mellman, 1996). 
 
1.1.1 Clathrin-Coated Vesicles 
 
The use of clathrin coats is one of the mechanisms by which the cell forms 
vesicles. Clathrin is a coat protein. Three coat complexes have been well 
characterised, clathrin, coat protein-I (COP-I), and coat protein-II (COP-II) (Glick and 
Malhotra, 1998). COP-I coats are found on vesicles that travel between the Golgi 
apparatus and the endoplasmic reticulum, and also between the Golgi and late 
endosomes. COP-II coats are also involved in transport from the ER to the Golgi. 
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Clathrin coats are involved in transport of vesicles from the plasma membrane to 
early endosomes, and from the trans-Golgi network (TGN) to endosomes. 
One of the early steps of endocytosis is the assembly of clathrin coats on the 
cytoplasmic face of the plasma membrane resulting in the formation of invaginated 
pits that eventually “pinch off” (scission) to become independent CCVs. Clathrin 
coats are primarily made up of an approximately 190kDa clathrin heavy chain (CHC) 
and a 25kDa clathrin light chain (CLC). These associate into CHC-CLC complexes 
that form three-legged trimers, known as triskelions. The triskelions oligomerise to 
form polygonal arrays that can form into a clathrin cage around lipid-vesicles. Pearse 
and colleagues used electron microscopy (EM) to determine the first structural map of 
a clathrin cage, which contains eight hexagons and twelve pentagons (thirty-six 
triskelions) (Crowther and Pearse, 1981; Smith et al., 1998).  
Other components of the clathrin coat include assembly protein 180 (AP180) 
and the adaptor proteins (APs). AP180 has been shown in vitro to have assembly 
properties i.e. promotes the formation of clathrin coats. Adaptor proteins are the first 
to be recruited to membranes and provide the binding site for clathrin coats. Their 
other crucial function is to interact with cell surface receptors that carry specific target 
signals that program them for sorting into CCVs. As with the coat proteins, there are 
several adaptor protein complexes. Each complex contains four polypeptides 
(adaptins), two 100kDa heavy chains, a 50kDa (medium) chain, and a small 25kDa 
chain (Figure 1). The two heavy chains have appendages, known as ear domains, 
that protrude from the complex and to which several proteins involved in endocytosis 
have been shown to bind, these include amphiphysin, Eps15, and epsin. Genomic 
analysis of the adaptor complexes in a number of eukaryotic organisms has revealed 
that while the number of complexes remains relatively constant from yeast to human, 
the number of subunits has increased, from 31 in yeast to 53 in human (Bock et al., 
2001). Thus, instead of evolving new adaptor complexes to accommodate the 
increased complexity of the trafficking system, mammals have adapted by exchanging 
subunits. For example, the AP-1 complex can interchange between two medium 
subunits, but only 1B can transport low-density lipoprotein and transferrin receptors. 
The AP-1 complexes are found associated with CCVs derived from the TGN, and 
their chains are designated and . AP-2 complexes are associated with 
CCVs originating from the plasma membrane and have polypeptides designated 
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and (Robinson, 1994)Other adaptor complexes include AP3 and AP4, 
however, these are not as well characterised (Hirst et al., 1999; Simpson et al., 1997); 
 
 
 
 
 
 
 
Figure 1. Schematic representation of the four known adaptor complexes 
(www.cimr.cam.ac.uk/cellbiol/robinson).  
 
In addition to the core scaffold proteins of clathrin coats, there are many other 
proteins that can bind clathrin or adaptor complexes. These are thought to play roles 
in modulating cage assembly, its disassembly, and the eventual recycling of the coat 
components. One of the proteins involved in the scission event is the GTPase 
dynamin. In Drosophila that carry the Shibire mutation, a temperature-sensitive 
mutation in dynamin, and in cells that express a GTPase defective form of dynamin, 
clathrin coated pits appear to accumulate on the plasma membrane with very little 
CCV formation. Dynamin can also be seen on the necks of deeply invaginated pits by 
EM. It is likely that dynamin may constrict the neck of emerging vesicles, and in 
conjunction with the closing of the clathrin cage, result in the pinching off of the 
newly formed vesicle from the plasma membrane. However, dynamin is not 
exclusively involved in budding of CCVs from the plasma membrane, there are at 
least twenty isoforms of dynamin, some of which have been implicated in Golgi 
function, caveolae formation, and mitochondrial biogenesis (Schmid et al., 1998). 
 
1.1.2 The Early Sorting Endosome and Recycling Compartment 
 
The early sorting endosome is the ‘junction’ between the recycling and the 
degradative pathways. The physical structure of the early endosome is complex, 
consisting of large vesicles (300-400nm in diameter) from which thin tubules (approx. 
60nm in diameter) emanate. The vesicles contain invaginations and closely resemble 
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the multivesicular bodies (MVBs) of the degradative pathway, while the tubular 
elements resemble the tubules of the recycling compartment. While the boundary 
between the early sorting endosome and the late endosomes can be readily 
distinguished, in some cell lines it is difficult to determine a boundary between the 
recycling compartment and the early sorting endosome. It is in the early sorting 
endosome that proteins and lipids, internalised from the plasma membrane, are sorted 
into cargo that is to be degraded, or recycled. Cargo from the early sorting endosome 
is either transported directly to the plasma membrane, in the ‘fast’ recycling pathway, 
or sent to the recycling compartment for recycling along the ‘slow’ pathway. Sorting 
motifs have been found on the cytoplasmic domains of a number of proteins that are 
destined for the degradative pathway, including the EGFR, P-selectin, and the IL-2 
receptor. However, no recycling motifs have been identified, leading to the suggestion 
that recycling to the cell surface occurs by default. The lipid composition of the 
sorting endosome is not uniform, which may provide a means by which proteins in 
the early endosome are segregated. Different lipid domains, with associated cargo, 
may accumulate at the regions of tubule or MVB formation, depending on their fate 
(Gruenberg, 2001). Lipid rafts, assemblies of cholesterol and sphingolipids, may have 
sorting roles in the early endosome. 
The recycling compartment is composed of distinct tubules that are generally 
found close to the microtubule organising centre (MTOC). They are slightly less 
acidic than sorting endosomes and do not contain ligands or receptors destined for the 
degradative pathway. Traffic has been observed from the recycling compartment to 
the plasma membrane (the ‘slow’ recycling pathway), and also from the recycling 
compartment to the trans-Golgi network (Ghosh et al., 1998). Transport from the 
recycling compartment is dependent on microtubules, actin, and unconventional 
myosins. There is considerable overlap in the distribution of the key components that 
regulate transport to and from the sorting endosomes and recycling compartment. For 
example, immunofluorescence, using fluorescent-tagged proteins, and biochemical 
techniques that use immunoadsorption and centrifugation to separate the two 
compartments, have clearly shown that there is significant overlap in the distribution 
of three Rab GTPases (Rabs 5, 4, and 11) involved in the receptor-recycling pathway 
(Sonnichsen et al., 2000; Trischler et al., 1999). Rab5, which regulates transport from 
the plasma membrane to the early endosome, shows some overlap with Rab11, which 
regulates transport through the recycling compartment. Even though there is overlap, 
 17
these Rab proteins interact with specific subsets of effectors that appear to be more 
precisely localised to the compartment upon which they function. Rab4 appears to 
function in between Rab5 and Rab11 in the recycling pathway. It regulates transport 
from the sorting endosome to the recycling compartment, or to the degradative 
pathway (McCaffrey et al., 2001; van der Sluijs et al., 1992), and shares an effector 
with Rab5, Rabaptin-5 (Vitale et al., 1998). It has been speculated that there is a 
similar protein that acts as an intermediate between Rab4 and Rab11 (Sonnichsen et 
al., 2000). 
Note:-the nomenclature used to describe the compartments along the recycling 
pathway can be confusing. When referring to the early endosome, some authors 
describe it as being composed of both the sorting endosome and the recycling 
compartment, while others describe the early endosome as the equivalent to the 
sorting endosome, and distinct from the recycling compartment, or recycling 
endosomes.   
 
1.1.3 The Degradative Pathway 
 
Cargo that is destined to travel along the degradative pathway is transported to 
the late endosomes, from the early sorting endosome, in large multivesicular bodies. It 
is not clear if MVBs are transport intermediates between two stable compartments, or 
if they eventually mature into late endosomes. Mutivesicular bodies consist of two 
membranes, an outer limiting membrane, and an internal membrane with many 
invaginations. The outer membrane does not contain any early endosomal markers, 
and lacks LAMP1, which is abundant on late endosomal membranes. Similar to early 
endosomes, late endosomes are highly pleiomorphic, containing a cisternal region, 
tubules, and vesicular regions with invaginations. Their limiting membranes contain 
high quantities of the protein LAMP1, which is protected from degradation by its 
glycosylation state. The inner membrane is partially composed of the phospholipid, 
lysobisphosphatidic acid (LBPA). LBPA is resistant to degradation by 
phospholipases. It has been proposed that LBPA presents proteins and lipids to the 
degradation machinery. Mannose 6-phosphate receptors (M6PRs) travel from the 
TGN to late endosomes, where they deliver lysosomal enzymes. The distinction 
between late endosomes and lysosomes is even more blurred than that between early 
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sorting endosomes and late endosomes. They both have an approximate pH of 5.5, 
and their outer membranes are primarily composed of the same glycoproteins. They 
share the same docking/fusion machinery and can rapidly exchange phospholipids and 
membrane proteins. However, lysosomes are more electron-dense than late 
endosomes, and lack M6PR, Rab7, and Rab9, or phosphorylated hydrolase precursors 
(Gruenberg, 2001).  
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Figure 2. Outline of the endocytic pathway. The recycling pathway is indicated by 
green arrows, and the degradative pathway by red arrows. The blue arrow represents 
transport between the TGN and the recycling compartment. 
       
1.2 The SNARE Hypothesis 
 
SNAREs, or SNAP receptors, are a family of integral membrane proteins that 
are involved in mediating the fusion of vesicles. They are generally between 15 and 
45kDa in size. They are anchored to their specific membrane via their carboxy-
terminus, while their central region and amino-termini are cytoplasmic. Specific 
subsets of SNAREs found on the target membrane (t-SNAREs) interact with specific 
SNAREs on the vesicle membrane (v-SNAREs). Coiled-coil domains in their 
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cytoplasmic region mediate these protein-protein interactions. SNAREs are specific to 
particular transport pathways, and some are also cell-type specific. Syntaxins are a 
family of t-SNAREs, syntaxin 1 is a neuronal-specific t-SNARE, while syntaxin 2 is 
found at the apical membrane of epithelial cells. Synaptobrevin 3 (also known as 
cellubrevin) is an example of a ubiquitously expressed v-SNARE that localises to the 
perinuclear recycling compartment.  
The involvement of SNAREs in membrane fusion can be described as a series 
of distinct steps. Taking the t-SNARE syntaxin 1 as an example, initially it is in a 
‘closed’ conformation. This conformation is maintained by a specific alpha-helix, the 
H3 helix, which is bound by a three helix bundle (the inhibitory domain) located at 
the syntaxin amino-terminus. The resulting four-helix bundle cannot bind its cognate 
v-SNARE. Step 1 involves the conversion of syntaxin 1 from its ‘closed’ 
conformation to an ‘open’ conformation. In step 2, the v-SNARE binds to the H3 
helix of syntaxin and also to a second t-SNARE. This results in the formation of a 
trans-SNARE complex, in which the vesicle is ‘pinned’ to the target membrane by the 
two sets of SNAREs. In step 3, membrane fusion occurs, the SNAREs are now on the 
same membrane in a cis-SNARE complex. Step 4 is the disassembly step, in which 
the SNAREs are separated and recycled for further rounds of fusion. In step 5 
syntaxin reverts back to its ‘closed’ conformation (Carr and Novick, 2000). These 
steps are regulated by a large number of accessory factors. Important among these, are 
NSF (N-ethylmaleimide-sensitive fusion protein), and -SNAP (soluble NSF 
attachment protein), which are involved in the disassembly of the cis-SNARE 
complex. Sec1 is thought to be part of the machinery that converts syntaxin 1 from its 
‘closed’ conformation to its ‘open’ conformation (Misura et al., 2000).     
Accuracy in membrane fusion is vital for the growth and division of cells, and 
for maintaining the spatial organisation of biochemical events within the cell. The 
SNARE hypothesis proposed that v- and t- SNAREs provide the specificity for 
membrane docking and fusion (Rothman, 1994). This view was consistent with the 
observation that ER to Golgi transport in yeast can proceed in the absence of the yeast 
Ypt1 GTPase, if the v- and t-SNAREs involved in the pathway are overexpressed 
(Dascher et al., 1991). This hypothesis has proved controversial ever since it was 
proposed. A body of work implicates the Rab GTPases and additional peripheral 
membrane proteins as providing the specificity for the docking events, and that the 
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SNAREs are simply present to drive the fusion event. Cao and colleagues used a yeast 
in vitro fusion system that measures the fusion of ER-derived vesicles to Golgi 
membranes. They demonstrate that Uso1p, a peripheral membrane protein, is required 
for docking and that removal of Ypt1p from the membranes with GDI inhibits this 
docking step. Fusion is not inhibited if GDI is added after docking has occurred. 
Using temperature sensitive SNARE mutants they show that this Ypt1p-regulated 
docking event is independent of SNARE function (Cao et al., 1998). Other studies 
that analysed the interactions of purified SNARE proteins revealed that they were 
promiscuous in their interactions i.e. the authors observed interactions between 
SNAREs that could not realistically interact in vivo due to their subcellular 
localisation and participation in different transport pathways (Fasshauer et al., 1999; 
Yang et al., 1999). The conclusion was that since v- and t- SNAREs did not interact 
exclusively with their cognate partners they could not provide the specificity for the 
vesicle docking and fusion events. 
Recent work from Rothman and colleagues has shifted the balance of results 
back in favour of the SNARE hypothesis. They used an in vitro assay in which 
purified yeast SNAREs were reconstituted in liposomes. This assay differs from 
previous assays in that interactions are measured between SNAREs that are in their 
natural membrane anchored conformation. The ability of all the known v-SNAREs in 
the yeast genome to trigger fusion by pairing with the t-SNAREs that label the plasma 
membrane, vacuole, and Golgi, was tested. Of the 33 possible combinations, only the 
four previously known cognate combinations and 2 new combinations had the ability 
to mediate fusion reactions (McNew et al., 2000). Using this assay to analyse in detail 
the ER to Golgi fusion event, which involves the four SNAREs, Sed5, Bos1, Sec22, 
and Bet1, each of which contribute a single helix to the SNARE complex, it was 
demonstrated that only one combination in which the v-SNARE Bet1 is on one 
membrane, and the remaining three t-SNAREs are on the other, allows fusion to occur 
(Parlati et al., 2000). Thus each SNARE is restricted by design to function as either a 
v-SNARE, or as part of a t-SNARE complex.  
 To conclude, the recently available data indicate that the SNARE hypothesis 
holds true. The specificity of intracellular membrane fusion appears to be mediated, to 
a large extent, by the SNARE proteins. However, even though a significant part of the 
specificity of vesicle transport is determined by the specificity inherent in cognate 
SNARE complexes, it is likely that this is complemented by a large number of 
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accessory proteins. These accessory proteins may be regulated by the activation state 
of specific Rab GTPases. The protein complexes recruited to vesicle membranes by 
activated Rabs are likely to have complementary, rather than redundant properties, 
with respect to the SNARE proteins. They are involved in the tethering of vesicles, 
their movement, and may permit the fine spatial and temporal control of fusion, by 
regulating the localisation and activation state of the SNAREs. Rothman et al propose 
that SNAREs provide the core, evolutionarily conserved, mediators of membrane 
compartment specificity, while Rab GTPases provide the fine-tuning for this 
specificity.  
 
1.3 The Rab Family of Small GTPases 
1.3.1 The Evolution of Rab Family 
 
Rab GTPases (‘Ras-related in brain’), and their yeast counterparts, Ypt 
proteins, form the largest branch of the Ras superfamily of small GTPases. They are 
evolutionarily conserved and are present in all eukaryotes investigated. Yeast has 11 
members, while C. elegans and D. melanogaster have 29 and 26 members, 
respectively (Stenmark and Olkkonen, 2001). The human genome project has allowed 
the identification of at least 60 members in the human Rab subfamily (Bock et al., 
2001). Most Rab proteins are ubiquitously expressed, however, a number such as 
Rab3A, which has been implicated in secretion in neuroendocrine cells, are cell-type 
specific. Ten Rab subfamilies have been identified, the members of which appear to 
be the result of gene duplications and are between 75-95% identical (Figure 3). 
Members of these subfamilies have similar subcellular localisation and some 
functional overlap. Rab GTPases share their highest sequence conservation at their 
nucleotide binding domains, and are most divergent at their carboxy-termini, which 
are involved in their subcellular targeting (Chavrier et al., 1991). Crystallographic 
studies have identified two regions, switch I and switch II, which undergo extensive 
conformational changes depending on the nucleotide-bound state of the Rab GTPase. 
These switch regions are important for binding to regulatory proteins such as GAPs 
and GEFs. 
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Resolution of the crystal structure of Rab3a, bound to its effector Rabphilin-
3a, indicates that the switches form a major part of the interaction interface between 
the two proteins (Ostermeier and Brunger, 1999). Bioinformatic analysis of the amino 
acid sequences of the Rab family has identified four regions, close to the switch 
domains, that can be used to distinguish between subfamilies. These RabSF regions 
are present on two different surfaces of the protein and are proposed to allow the 
specific binding of downstream effector proteins (Moore et al., 1995). It has been 
proposed that regulatory proteins and downstream effectors bind to the switch 
regions, to determine the nucleotide-bound state of the GTPase, and to the RabSF 
domain, to determine the subfamily specificity.  
Rab GTPases localise to the cytoplasmic face of intracellular compartments 
where they regulate specific transport events (Figure 4). When in their GTP-bound, 
active, conformation they can recruit effector molecules. It has been difficult to 
identify novel Rab effectors by bioinformatic approaches, as they tend to be very 
divergent. There are potentially many more Rab effectors than Rab GTPases, since 
several Rabs have been shown to have more than one effector. The GTP-bound form 
of Rab5 has been shown to interact specifically with at least 20 different proteins 
(Christoforidis et al., 1999a). Some effectors have coiled-coils and are involved in 
vesicle tethering and fusion, while some are enzymes, or cytoskeletal motor proteins. 
Identification of Rab effectors, and regulatory proteins, is a very important part in 
understanding the function of Rab GTPases.    
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Figure 3. Phylogenetic tree of the human Rab GTPase family (Bock et al., 2001). 
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Figure 4. Intracellular transport pathways regulated by Rab GTPases (Stenmark and 
Olkkonen, 2001). 
         
1.3.2 The Rab Cycle 
 
Rab proteins, in common with the other GTPases of the Ras superfamily, 
cycle between an active and an inactive conformation. They are in their active, 
membrane-bound, state when bound by GTP. Hydrolysis of the GTP to GDP results 
in the conversion to their inactive conformation. Various accessory factors regulate 
this cycle. The current view of the Rab cycle proposes that GDP-bound Rab is 
maintained in the cytosol by Rab GDI (GDP-dissociation inhibitor), of which there 
are several isoforms in mammalian cells. Rab GDI has the ability to extract GDP-
 25
bound Rab from membranes, but it can also deliver the Rab-GDP to its target 
membrane from the cytosol. Following delivery of the Rab to its specific 
compartment, a factor displaces Rab GDI enabling Rab-GDP to bind to the 
membrane. This may be mediated by a unique receptor on the target membrane (Ayad 
et al., 1997). Next, the GDP is replaced with GTP by an exchange factor, or Rab GEF 
(guanine nucleotide exchange factor). GTP-bound Rab is now resistant to extraction 
by Rab GDI. Exchange factors can be highly specific, such as Rab3-GEF, or can have 
a broad substrate specificity, such as Mss4 (Burton et al., 1994). These factors are 
very important in the transport process as they ensure the correct targeting and 
activation of the Rab GTPase. The GTP-bound Rab is now able to perform its 
regulatory function, usually as part of a large complex of effector proteins. Rab 
GTPase-activating proteins (Rab GAPs) stimulate the intrinsic GTPase activity of the 
Rab protein resulting in the conversion of the GTP to GDP, allowing Rab GDI access 
to the membrane-bound Rab, and its extraction from the membrane (Figure 5). The 
cycle starts over again; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Overview of the Rab cycle (www.mpi-dortmund.mpg.de/departments 
/dep3/alexandrov/kirillfinal/rab_cycle.html). 
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In order for Rab proteins to bind membranes they must possess one, or two, 
C20 geranylgeranyl lipid groups at their carboxyl-terminus. The process by which 
they gain these lipid moieties is known as prenylation. Newly synthesised, 
unprenylated, Rab GTPases are bound by REP (Rab escort protein) and delivered to 
geranylgeranyl transferase (GGTase). GGTase is an enzyme that catalyses the 
attachment of the lipid groups to two carboxy-terminal cysteine residues present on all 
Rab GTPases (Anant et al., 1998). REP shares a strong homology with Rab GDI and 
can itself deliver Rab proteins to membranes following geranylgeranylation. 
However, none of the Rab GDIs can replace REP. REP appears to be a specialised 
Rab GDI that can deliver newly synthesised, GDP-bound, Rab proteins to GGTase for 
isoprenylation, and then transport the modified Rab protein to its target membrane. 
Rab GDI then takes over in the subsequent cycling between cytosol and membrane.    
 
1.3.3 The Role of Rab5 
 
Rab5 is one of the most characterised Rab GTPases. It localises predominantly 
to the sorting endosome, but is also found at the plasma membrane. It has been 
implicated in the budding of vesicles from the plasma membrane, regulating 
endosomal membrane fusion, and cytoskeletal transport. Overexpression of wild-type, 
or constitutively active Rab5, Rab5Q79L, leads to an increase in the rate of ligand 
internalisation from the plasma membrane, and the formation of abnormally large 
early endosomes (Bucci et al., 1992; Gorvel et al., 1991). Rab5-GTP was shown to 
promote the homotypic fusion of sorting endosomes, and the heterotypic fusion of 
plasma membrane derived clathrin coated vesicles (CCVs) with early sorting 
endosomes. It is postulated that these activities are regulated by the recruitment of a 
scaffold of cytosolic proteins. Rab5-GTP has been demonstrated to interact 
specifically with at least 20 different cytosolic proteins (Christoforidis et al., 1999a; 
Christoforidis et al., 1999b). These include Rabaptin-5 and Rabex-5. Rabaptin-5 is a 
100kDa protein that forms a homodimer and interacts with Rab5 at its C-terminus 
(Stenmark et al., 1995). Rab5-GTP recruits Rabaptin-5 and Rabex-5, a Rab5-specific 
guanine nucleotide exchange factor, to the sorting endosomes. These proteins 
downregulate the intrinsic Rab5 GTPase activity thus providing a positive-feedback 
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loop that stabilises Rab5 on the membrane, and may generate areas of localised Rab5 
accumulation (Horiuchi et al., 1997; Lippe et al., 2001).  
Another homodimer, and Rab5 effector, is early endosomal antigen1 (EEA1), 
which is also essential for endosome fusion (Christoforidis et al., 1999a; Mu et al., 
1995; Stenmark et al., 1996).  EEA1 is found on early endosomes and is thought to be 
involved in the docking process. It provides the directionality in the docking of CCVs 
with early endosomes, since Rab5 and Rabaptin-5 are found on both sets of 
membranes whereas EEA1 is recruited selectively to early endosomes (Rubino et al., 
2000). Its binding to early endosomes is mediated via a phosphatidylinositol-3-
phopspahte [PI(3)P] lipid-binding FYVE domain (Stenmark et al., 1996). EEA1 has 
the ability to bind the SNARE protein, syntaxin 13, thus providing a link between the 
SNARE complex and the Rab5 complex (McBride et al., 1999).  
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Rab5 recruits a scaffold of effector and regulator proteins to the 
cytoplasmic face of the early endosome (Zerial and McBride, 2001). Rab5-GTP, 
denoted as T is bound to the membrane, while Rab5-GDP, represented as D, is free in 
the cytoplasm.  
 
Rab5 is also involved in the recruitment of cargo into clathrin-coated pits 
(McLauchlan et al., 1998), and in the regulation of endosome motility via the 
recruitment, or activation, of a minus-end directed motor protein (Nielsen et al., 
1999). Thus a picture emerges of Rab5 regulating most aspects of the plasma 
membrane to early sorting endosome transport pathway, from the formation of 
clathrin coated pits, to the transport of CCVs to the early sorting endosome, and 
 28
finally to the docking and fusion of the CCVs with the sorting endosome. These 
diverse functions are regulated by the selective recruitment, by Rab5-GTP, of an array 
of proteins to specific locations along this pathway. There is increasing evidence that 
other Rab GTPases may also have similar ‘universal’ roles (see below).   
 
1.3.4 Rab4 Regulates Transport from the Sorting Endosome 
 
Rab4 is localised primarily to the early sorting endosome (Daro et al., 1996; 
Van Der Sluijs et al., 1991), although a minor pool is associated with the Rab11-
positive recycling compartment (Sonnichsen et al., 2000; Trischler et al., 1999). Rab4 
is involved in regulating transport along both the recycling and degradative pathways 
(McCaffrey et al., 2001; van der Sluijs et al., 1992). It is thought to regulate the 
recycling of receptors from the sorting endosomes either, directly back to the plasma 
membrane (Daro et al., 1996), or via the pericentriolar recycling compartment 
(Mohrmann and van der Sluijs, 1999). Expression of a dominant negative mutant of 
Rab4, Rab4S22N, in mammalian cells results in an inhibition of both recycling and 
degradation. Overexpression of wild-type Rab4, or a dominant positive mutant, 
Rab4Q67L, causes the formation of a tubular network accessible to FITC-Tfn 
(McCaffrey et al., 2001). During mitosis Rab4 is phosphorylated by p34cdc2 kinase, 
which results in its translocation from the sorting endosomes to the cytoplasm, where 
it is retained by the peptidyl-prolyl isomerase, Pin1 (Barbieri et al., 2000; Gerez et al., 
2000). This may be one mechanism by which the endocytic pathway is shut down 
during cell division.  
Rab4 plays a regulatory role during the insulin-stimulated uptake of glucose in 
adipose and muscle cells. Insulin induces the translocation of a glucose transporter 
protein, GLUT4, from an intracellular store to the plasma membrane. Rab4 is present 
on GLUT4-containing vesicles and undergoes an insulin-induced redistribution from 
membranes to the cytosol. To determine whether Rab4 has a direct role in insulin-
stimulated glucose transport, Shibata et al demonstrated that a peptide, corresponding 
to part of the carboxy-terminal hypervariable region of Rab4, inhibits GLUT4 
translocation to the plasma membrane in permeablised rat adipocytes, as does the 
presence of anti-Rab4 antibodies (Shibata et al., 1996). In contrast, peptides 
corresponding to the hypervariable-domains of Rab3C and Rab3D had little effect, 
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despite the fact that Rab3D is predominately expressed in this cell line. It was 
demonstrated that insulin stimulates the binding of GTP by Rab4, via a 
phosphoinositide 3-kinase dependent pathway (Shibata et al., 1997).  
A number of Rab4 interacting proteins have been identified. These include 
Rabaptin-5/Rabaptin-4 (Nagelkerken et al., 2000; Stenmark et al., 1995; Vitale et al., 
1998), syntaxin 4 (Li et al., 2001), Rabip4 (Cormont et al., 2001), and the light 
intermediate chain-1 of the motor protein dynein (Bielli et al., 2001). Rabaptin-5 is a 
100kDa protein that was identified in a yeast two-hybrid screen for Rab5 effectors. It 
was subsequently shown to interact with Rab4. The Rab interacting domains of 
Rabaptin-5 differ. Rab5 interacts with the carboxy-terminus of Rabaptin-5, whereas 
Rab4 binds to its amino-terminus. Rabaptin-5 is recruited from the cytosol, to the 
early sorting endosomes by GTP-bound Rab5. However, activated Rab4 does not 
appear to be able to recruit Rabaptin-5. It was postulated that Rab4 interacts with 
Rabaptin-5 that has already been recruited to the early endosome by Rab5. Since 
Rab5 and Rab4 cooperate in regulating the transport influx into, and efflux out of, 
early endosomes, Vitale et al. propose that Rabaptin-5 acts as a ‘molecular bridge’ 
that links these two sequential transport events (Vitale et al., 1998). 
Li et al. recently demonstrated that Rab4-GTP has the ability to bind syntaxin 4, 
a t-SNARE found at the plasma membrane (Li et al., 2001). This interaction requires 
syntaxin 4 to be in the open conformation. The authors propose that syntaxin 4 is a 
target for Rab4-regulated vesicles, and provides a method by which Rab4 can direct 
the docking/fusion of transport vesicles with the plasma membrane. A yeast two-
hybrid screen (our laboratory) identified the dynein light intermediate chain-1 as a 
Rab4-GTP interacting partner (Bielli et al., 2001). Dynein is a motor protein that 
directs retrograde transport along microtubules. It is proposed that Rab4 directs the 
cytoskeletal transport of vesicles from the sorting endosome via its interaction with 
the dynein complex.   
Rabip4 is a 69kDa, FYVE domain-containing, protein. It colocalises with EEA1 
and Rab4 on the early sorting endosome, but does not colocalise with Rab11 at the 
recycling compartment.  In common with Rabaptin-5 it has a number of coiled-coil 
domains. It is a membrane bound protein, cooverexpression of Rabip4 with 
Rab4Q67L leads to an enlargement of the sorting endosome and to an increase in the 
overlap between Rab5 and Rab4, and Rab4 with Rab11b. Expression of Rabip4 leads 
to the intracellular retention of the glucose transporter, GLUT1. It is proposed that 
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Rabip4 functions as the acceptor, on the sorting endosomes, for the pool of Rab4 that 
is regulating traffic back from the recycling compartment. From the available 
evidence it is emerging that Rab4 is a key regulator in the sorting process that occurs 
in the early sorting endosome, and that it regulates a number of different transport 
steps from this compartment. However, additional work is necessary to determine 
more precisely its role(s) in intracellular trafficking.  
 
1.3.5 Rab11 Regulates Transport Through the Recycling Compartment 
 
The Rab11 family consists of three members, Rab11a, Rab11b, and Rab25. It is 
a ubiquitously expressed protein, however gastric parietal cells appear to possess the 
highest endogenous levels of Rab11a. Rab11 is found on the perinuclear recycling 
compartment and the trans-Golgi network (TGN) (Ullrich et al., 1996). It is involved 
in the regulation of transport from the recycling compartment, either back to the 
plasma membrane, or to the TGN (Urbe et al., 1993). Overexpression of a dominant-
negative mutant of Rab11, Rab11S25N, inhibits the recycling of Tfn from the 
recycling compartment (Ullrich et al., 1996), and results in the formation of an 
extensive tubular FITC-Tfn positive network in HeLa cells (Wilcke et al., 2000). This 
Rab11S25N-induced tubular network is inaccessible to EGF or Tfn internalised at 
19oC, suggesting that it is derived from the recycling compartment. Wilcke et al. 
demonstrate that Rab11 is also involved in transport from the endocytic compartment 
to the biosynthetic pathway by demonstrating that endogenous TGN38, a marker that 
cycles between the TGN and the plasma membrane, is redistributed into Tfn-positive 
structures in cells expressing the dominant-negative mutant. In polarised cells Rab11 
is associated with the apical recycling system. Overexpression of Rab25 in polarised 
MDCK cells results in an inhibition of transcytosis, and apical recycling (Casanova et 
al., 1999). 
 As with the other Rab GTPases discussed, a number of proteins have been 
shown to interact with Rab11. The first, Rabphilin-11/Rab11BP, was reported 
separately by two different groups (Mammoto et al., 1999; Zeng et al., 1999). 
Rabphilin-11 is an approximately 100kDa protein, the carboxy-terminus of which 
contains six WD40 domains. WD40 domains are approximately 42-44 amino acids in 
length and are thought to mediate protein-protein interactions. It is predominantly a 
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cytosolic protein but is recruited to the recycling compartment, and TGN, by Rab11-
GTP. Overexpression of full-length Rabphilin-11 had no effect on Tfn recycling, 
however, overexpression of a truncated form that contained the Rab11 binding 
domain, resulted in a dramatic inhibition. The authors of both studies propose that 
Rabphilin-11/Rab11BP is a downstream effector of Rab11. In a yeast two-hybrid 
screen that used the amino-terminal fragment of Rabphilin-11 as bait, Mammoto et al 
identified mSec13p as a Rabphilin-11 interacting partner (Mammoto et al., 2000). 
mSec13p is the mammalian homologue of yeast Sec13p which is involved, as part of 
the coat protein II (COPII) complex, in vesicle transport from the endoplasmic 
reticulum (ER). The role of mSec13p is unclear, but the authors show that it is 
localised to the ER and Golgi complex in BHK and MDCK cells. Rabphilin-11 and 
mSec13p colocalise in the perinuclear region, presumably the Golgi. Overexpression 
of active Rab11 enhances the Rabphilin-11/mSec13p interaction. The authors contend 
that the function of the Rab11/Rabphilin-11/mSec13p interactions in the cell are 
unclear, but hypothesise that one function could be in the budding of vesicles from the 
Golgi. 
Rip11 is a 72kDa protein that interacts preferentially with Rab11-GTP. It was 
identified as a protein from a rat brain extract that bound to the GTPase-deficient, 
Rab11Q70L (Prekeris et al., 2000). Microsequencing revealed that this protein 
matched the previously characterised KIAA0857 open reading frame. KIAA0857 had 
been described as a phosphoprotein, pp75, that was involved in the autoimmune 
condition lupus erythematosus (Wang et al., 1999). It is characterised by a C2-
phospholipid binding domain near its amino-terminus, and a coiled-coil region at its 
carboxy-terminus that mediates the interaction with Rab11. It is a predominantly 
membrane bound protein and Prekeris et al. localised Rip11 to the apical recycling 
compartment in polarised MDCK and Caco-2 cells. Overexpression of a truncation 
mutant, that contained the Rab11 binding domain, did not inhibit the trafficking of 
[125I] Tfn, which was not surprising since Tfn is recycled from the basolateral surface 
back to the basolateral plasma membrane in polarised cells. However, there was a 
significant inhibition of [125I] IgA transcytosis from the basolateral to the apical 
membrane. Analysis of the Rip11 primary sequence identified a number of putative 
phosphorylation sites. Treatment of Caco-2 cells with kinase and phosphatase 
inhibitors confirmed that the membrane binding of Rip11 is regulated by its 
phosphorylation state.  
 32
Prekeris et al. propose the following model for Rip11 function. Rip11 is 
recruited to the apical recycling compartment by Rab11-GTP, where it binds to 
neutral phospholipids via its C2 domain. The Rip11/Rab11-containing transport 
vesicle buds from this compartment and is transported to the apical plasma 
membrane, where Rip11 binds to an as yet unidentified receptor. After vesicle 
docking, a SNARE scaffold can form and mediate membrane fusion. Hydrolysis of 
GTP by Rab11 releases Rip11, and phosphorylation of Rip11 leads to its transfer to 
the cytosol from which it can be recruited back to the recycling compartment.  
MyosinVb, a member of the class V family of unconventional myosins, was 
identified as a Rab11 interacting protein in a yeast two-hybrid screen of a rabbit 
parietal cDNA library (Lapierre et al., 2001). Little is known about myosin Va or 
myosin Vb. Lapierre et al demonstrate that myosin Vb colocalises with Rab11 in the 
perinuclear region of HeLa and MDCK cells. No colocalisation was seen with Golgi 
markers. Overexpression of its carboxy-terminal 60kDa, which contains the Rab11 
binding sites but lacks the motor domain, in HeLa cells, results in an inhibition of the 
traffic of transferrin from the recycling compartment to the plasma membrane. 
Expression of this construct in MDCK cells caused an inhibition in the transcytosis of 
IgA, but did not affect the trafficking of Tfn internalised from the basolateral 
membrane. The authors propose that myosin Vb is involved in Rab11-regulated 
trafficking out of the recycling compartment. Myosin Vb can now join the list of 
motor proteins that interact directly with, or are regulated by Rab GTPases. It is 
increasingly likely that each Rab protein may interact with a motor protein. 
 
1.3.6 Cross-talk Between Rab GTPases and Signal Transduction 
Pathways 
 
Evidence is emerging that a number of different signalling pathways may 
mediate their effects on endocytosis via “cross-talk” with Rab GTPases. Such 
pathways include the stress response pathway and the EGFR-signalling pathway. Rac 
is a member of the Rho family of small GTPases (Rho GTPases function largely to 
regulate the actin cytoskeleton in response to signals from cell surface receptors), and 
is activated by the EGF receptor. The activation of Rac is mediated by Eps8, a 
substrate of the EGFR, in complex with Sos1 and the adaptor protein, E3b1. RN-tre 
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was identified as an Eps8 interacting protein. Recent work has demonstrated that RN-
tre is a Rab5-GAP, i.e. stimulates the GTPase activity of Rab5 (Lanzetti et al., 2000) 
(see Figure 6). Thus, it was believed that RN-tre might provide a link between EGFR 
signalling and its endocytosis. Unlike the TfnR, which is constitutively endocytosed, 
the EGFR is internalised only upon activation by EGF. The authors demonstrated that 
RN-tre overexpression inhibits EGFR and TfnR internalisation. This inhibition was 
expected, since a Rab5-GAP would promote the conversion of active Rab5 to its 
GDP-bound, inactive form. To demonstrate a link between Rab5 and Rac signalling, 
RN-tre was overexpressed in Eps8 null fibroblasts. In these cells, trafficking of the 
TfnR was still inhibited, however internalisation of the EGFR was unaffected. Thus, 
the interaction between Eps8 and RN-tre is necessary for inhibiting Rab5 mediated 
ligand-dependent endocytosis. The authors propose that the RN-tre/Eps8 complex 
bound to the EGFR, excludes E3b1 from binding Eps8 and activating Rac. RN-tre 
localised to the EGFR inhibits Rab5-mediated endocytosis of the receptor. The 
binding of ligand to the EGFR results in the dissociation of RN-tre from Eps8, thus 
facilitating the binding of E3b1/Sos1 and the subsequent activation of Rac. The 
absence of RN-tre removes the block on EGFR internalisation and allows the 
downregulation of its signal.  
Guanine-dinucleotide dissociation inhibitor (GDI) is phosphorylated in the 
cytosol, suggesting that a kinase can regulate the membrane association of Rab 
GTPases. Cavalli et al. recently investigated the mechanism of this regulation by 
analysing the ability of GDI to extract Rab5 from early endosomes (Cavalli et al., 
2001). Using an assay in which purified GDI was used to extract Rab5 from early 
endosomes, the authors determined that GDI was activated by an enzyme present in 
the cytosol, and that this enzyme was probably a kinase since activation was inhibited 
by the presence of nonhydrolysable analogues of ATP. This factor was identified as 
the protein kinase p38 MAPK. H2O2 is an activator of p38 MAPK in the p38-
dependent stress response. It was shown that treatment with H2O2 resulted in 
increased GDI phosphorylation, and in the amounts of GDI:Rab5 complex in vivo. 
Specific inhibitors of p38 MAPK reduce the ability of GDI to extract Rab5. 
Immunofluorescence studies revealed that H2O2 causes a partial redistribution of the 
Rab5 effector EEA1, from membranes to the cytosol. H2O2 also stimulates the early 
stages of endocytosis. The authors propose the following model to explain this 
stimulation of endocytosis upon activation of p38 MAPK; they suggest that the 
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amount of the cytosolic GDI:Rab5 complex is rate-limiting at each round of transport 
[approximately 5-10% of Rab5 is cytosolic, the rest being membrane-bound. Recent 
studies have shown that only 10-20% of the membrane-associated pool of Rab 
proteins is sufficient to sustain growth in yeast]. The oxidative stress induced 
activation of p38 MAPK, activates GDI which extracts Rab5 that is undergoing futile 
GTPase cycles on the membrane, and delivers it to the plasma membrane where it can 
mediate the formation of endocytic vesicles. Alternatively, the Rab5 may be delivered 
to active regions of the membrane where it will regulate docking/fusion, or 
interactions with the cytoskeleton. 
A number of other Rab interacting proteins have been identified whose 
membrane-association appears to be mediated by phosphorylation, and are thus 
potential targets for regulation by external stimuli. The membrane binding of Rip11 is 
regulated by phosphorylation (Prekeris et al., 2000). Rab proteins themselves can be 
phosphorylated. Rab4 is phosphorylated upon activation of ERK1 kinase by insulin, 
which results in its redistribution into the cytosol (Cormont et al., 1994). It can be 
speculated that external stimuli contribute to the regulation of intracellular trafficking 
for the purposes of promoting repair (e.g. the stress-response), storage (e.g. the 
insulin-stimulated translocation of GLUT4 to the plasma membrane for the purpose of 
glucose uptake), and degradation (e.g. the downregulation of the EGF signal by 
transporting the EGFR to the lysosomes).   
     
1.3.7 The Involvement of Rab GTPases in Disease  
 
The completion of the human genome sequencing project has allowed the 
identification and functional characterisation of a large number of disease causing 
genes. It is becoming apparent that many of these mutated genes cause defects in 
intracellular trafficking (Aridor and Hannan, 2000). Several of these genetic diseases 
are the result of mutations in Rab GTPases, or their interacting proteins (Stenmark 
and Olkkonen, 2001). Griscelli syndrome is an autosomal recessive disorder that 
results in pigmentation defects. There are two variants of this disease, one that results 
in immunological defects, and the other is associated with neurological dysfunction. 
The former is caused by missense mutations in the Rab27a gene, and the latter is the 
result of mutations in myosin Va. Both are located side-by-side on chromosome 15, 
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and mysoin Va is a putative effector of Rab27a. Rab27a is involved in regulating the 
transport of melanosomes to the periphery of melanocytes, and it also regulates the 
secretion of lytic granules in cytotoxic T lymphocytes. Hence, the lack of functional 
Rab27a results in the loss of pigmentation and in the uncontrolled activation of T-
lymphocytes. Myosin Va is not involved in the exocytosis of lytic granules, hence its 
inactivation does not cause the immunological defects observed upon inactivation of 
Rab27a (Stenmark and Gillooly, 2001).  
Tuberin is a tumour suppressor gene that interacts with Rabaptin-5 and 
negatively regulates endocytosis by acting as a Rab5-GAP. Its inactivation causes 
tuberous sclerosis, a disease that results in malformations and tumours on the central 
nervous system (Xiao et al., 1997). Choroideremia is an X-linked disease that results 
in the degeneration of the pigment epithelium of the eye. It is caused by a defect in the 
REP-1 gene. REP-1 is one of the two isoforms of gernayl-geranyl transferase that 
prenylate Rab GTPases. REP-1 is essential for the prenylation of Rab27a in the retinal 
pigment epithelium. REP-2 appears to be sufficient for the efficient geranyl-
geranylation of all other Rab GTPases, in all other tissues. Thus, the lack of functional 
REP-1 results in non-functional Rab27a and the onset of the disease. The pathology of 
this disease may be caused by the degeneration of the retinal epithelium due to 
deficient melanosome transport, and hence lack of protection during light exposure 
(Stenmark and Olkkonen, 2001). Mutations in the GDI1 gene, which codes for GDI-
 have been found in a subgroup of patients with X-linked non-specific mental 
retardation. GDI- is particularly abundant in brain tissue, thus defective membrane 
recycling of one or more Rab GTPases in brain synapses is likely to be the cause of 
this condition.        
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 Materials and Methods 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2.1 Materials 
 
All chemicals were purchased from Sigma-Aldrich Ltd. All restriction enzymes 
and Taq polymerases were from Roche Diagnostics or New England Biolabs, unless 
otherwise stated. All bacterial media was purchased from Difco, and yeast defined 
media was from Bio101. The bacteria and yeast strains used are listed below. 
E.coli bacterial strains used, included; 
HB101 thi-1, hsd S20, (rB-,mB-), supE44, recA13, ara-14, leuB6, proA2, lacY1, 
 rpsL20(strr), xyl-5, mt1-1 
BL21(DE3)pLysS F-, ompT, hsdSB, (rB-,mB-), dcm, gal, (DE3), pLysS(Cmr) 
XL-1 Blue recA1, endA1, gyrA96, thi-1, hsdR17, supE44, relA1, lac [F’ 
proAB, lacIq, ZM15, Tn10, (Tetr)] 
 The strain of Saccharomyces cerevisiae used for all yeast two-hybrid work was; 
L40 MATa, trp1, leu2, his3, LYS2::lexA-HIS3, URA3::lexA-lacZ 
 
2.2 Yeast Two-Hybrid Methods 
2.2.1 Screening of an oligo-dT Primed HeLa cDNA Library 
 
S.cerevisiae L40 was transformed with the ‘bait’ vector, pVJL10 Rab4Q67L  
(-CXC). A fresh colony from the transformant plate was used to inoculate a DO W- 
(media lacking tryptophan) liquid culture. After growth overnight, the medium was 
diluted to an OD600=0.5 and allowed to grow for a further 2 hours. The cells were 
harvested and resuspended in 100mls of YPD (1% yeast extract, 2% peptone, 2% D-
glucose) and grown to an OD600=1.1. The cells were harvested as before, washed in 
0.1M lithium acetate/TE, and finally resuspended in 4ml 0.1MLiAc/TE. Fifty 
micrograms of the oligo-dT primed HeLa cDNA library (MATCHMAKER, 
Clontech) was mixed with denatured salmon testis DNA and added to the cell 
suspension. Twenty-eight millilitres of 50% polyethylene glycol/0.1M LiAcTE was 
added, and the mixture was incubated for 30 minutes at 30oC. After this incubation, 
3.5ml DMSO was added and the cells were heat-shocked at 42oC for 20 minutes. The 
cells were pelleted, washed once in DO W-L- (media lacking tryptophan and leucine) 
liquid medium, and resuspended in 100ml of the same medium. This culture was 
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grown for 8 hours, harvested, and plated on DO W-L-H- (media lacking tryptophan, 
leucine, and histidine) agar plates. Colonies that appeared after 3 to 5 days of 
incubation were patched onto DO W-L- plates for further analysis.  
 
2.2.2 Yeast Transformations 
 
One hundred millilitres of fresh YPD was inoculated with a 10ml overnight 
culture of L40. The culture was incubated in a 30oC shaking incubator for 
approximately 2 hours until it reached a titre of 1-3x107 cells/ml. The cells were then 
pelleted at 1000g for 5 minutes, and the pellet was washed with 45ml 0.1M lithium 
actetate/TE, then resuspended in 2mls 0.1M lithium acetate/TE and incubated for 1 
hour at 30oC. Meanwhile, plasmid mixtures were prepared. 1-2g each, of the ‘bait’ 
and ‘prey’ plasmids were mixed with 4l of denatured salmon testes DNA (10mg/ml). 
150l of the L40 in 0.1M lithium acetate/TE was added to the plasmid mixture and 
incuabted at 30oC for 10 minutes, followed by the addition of 500l of 50% 
polyethylene glycol (PEG, M.W. 3350) in 0.1M lithium acetate/TE. Incubation at 
30oC, with occasional mixing, was continued for 1 hour. The yeast was then heat 
shocked at 42oC for 25 minutes. The transformations were spun for 5 seconds at top-
speed in a bench-top centrifuge. The pellets were washed twice with distilled water 
and resuspended in 200l dH2O. The resuspended cells were plated on selective 
media, lacking leucine and tryptophan (DO W-L-), and incubated for 3 days in a 30oC 
plate incubator. 
 
2.2.3 Rescue of Library Plasmids from S.cerevisiae L40 
 
Single colonies were picked and grown overnight at 30oC in 100ml DO L- 
medium. The cells were pelleted and resuspended in 5ml yeast lysis buffer (2% Triton 
X-100, 1% SDS, 1M NaCl, in TE). An equal volume of phenol/chloroform/isoamyl 
alcohol (25:24:1) and 2g glass beads (0.45mm diameter, Sigma) were added and the 
solution was vortexed for 15 minutes. The debris was pelleted at 3000g for 5 minutes. 
The DNA-containing, aqueous phase, was transferred to a fresh tube and ethanol 
precipitated. The DNA pellet was resuspended in 10l of dH2O and used to transform 
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E.coli HB101 cells. Several colonies were picked and a quick screen method was used 
to identify library plasmids, which were approximately 10kb in size compared with 
the bait plasmid of 5.6kb. 
 
2.2.4 -galactosidase Filter Assay 
 
Clones were patched onto DO W-L- plates and grown overnight at 30oC. A 
sterile Whatman 40 filter was placed on a fresh W-L- plate, onto which the patches 
were replica plated. The patches were grown on the filter overnight at 30oC. Once the 
patches had grown the filter was lifted from the plate and snap-frozen in liquid 
nitrogen. After thawing, the filter was soaked in Z Buffer (60mM Na2HPO4, 40mM 
NaH2PO4, 10mM KCl, 1mM MgSO4, pH 7) containing 6.75l-ME and 25l 2% X-
Gal, and placed in a 30oC incubator. A blue colour was allowed to develop. The 
reaction was stopped after 2 hours by soaking the filter in 1M Na2CO3. 
  
2.2.5 -galactosidase Liquid Assay 
 
Five millilitres of DO W-L- liquid media was inoculated with several colonies 
from a freshly grown transformation plate and grown overnight at 30oC, with shaking. 
The overnight culture was titred (OD600 0.1=~1x106 cells/ml) and subcultured into 
10ml of fresh media, to a titre of 5x106 cells/ml. This was incubated for 
approximately two hours until the titre was 1-2x107 cells/ml. The OD600 of this culture 
was taken by diluting 500l of the culture into 500l of dH20. Three millilitres of the 
culture was pelleted and resuspended in 100l of Z Buffer (60mM Na2HPO4, 40mM 
NaH2PO4, 1mM KC1, 0.1mM MgSO4). The resuspended pellet was snap-frozen in 
liquid nitrogen three times, after which 700l of Z Buffer with 0.03% -
mercaptoethanol (-ME) was added. 160l of a freshly made solution of ONPG 
(4mg/ml), in Z Buffer, was added and the reaction was allowed to proceed, at 37oC, 
until a yellow colour developed. The reaction was stopped immediately with 400l 
1M Na2CO3.  The start and finish time was noted. Cell debris was pelleted at 13,000g 
for 5 minutes. The OD420 of the supernatant was measured. The units of 
galactosidase activity were calculated using the following equation; 
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    Units=(OD420x1000)/(t x V x OD600)  
 
‘t’ is the elapsed time (in minutes), V is the volume of culture used in 
millilitres, and OD600 is the optical density of the culture. 
Note: Most incubation times for reactions containing two interacting hybrid 
proteins were usually no longer than five minutes. All reactions that showed no colour 
after 30 minutes were stopped at that point. 
 
2.3 Molecular Biology 
 
Subcloning, bacterial transformations, agarose gel electorphoresis, and 
purification of DNA bands from agarose gels, were performed using standard 
molecular biology techniques, or according to the protocol supplied by the 
manufacturer of the reagent or kit used. All cDNA fragments that were amplified by 
PCR were verified by sequencing (Dept. Biochemistry, Oxford University).  
 
2.3.1 Plasmids 
 
The vectors, pcDNA3.1HisB H13, and pTrcHisC H13, were constructed by 
ligating the 1kb EcoRI fragment from pGADGH H13 into the EcoRI sites of both 
vectors. RCP was amplified from a placental cDNA library using Vent DNA 
polymerase (NEB) and the primers RCP Fwd and GSP6. The primers contained 
BamHI restriction sites at their 5’ends. The product was cleaned up using the 
Geneclean II kit (BIO101) and digested with BamHI and ligated ‘in-frame’ into the 
BamHI sites of pGADGH, pGEX6P-1, and pcDNA3.1HisB. Full-length RCP was 
encoded in IMAGE Clone 3956619. The approximately 2.2kb from EST 3956619 was 
subcloned into the EcoRI site of the pGEM1 vector, and hence put under the control 
of the T7 promoter. Rab4WT was digested from pTrcHisA and subcloned into the 
BamHI site of the GST-expression vector, pGEX2T. The Rab11 effector mutant was 
constructed by two-step site directed mutagenesis, using a mutagenic primer that 
introduced a glutamate codon for the isoleucine at amino acid position 44, and an 
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upstream vector primer. The product of this reaction was used as the upstream primer 
in the second step in conjunction with a downstream vector primer. 
KIAA0941 was requested from the Kazusa DNA Databank, where it had been 
cloned into the pBluescript SK II vector. The open-reading frame was amplified using 
Expand DNA polymerase (Roche) with the KIAA0941Fwd(+EcoRI) and 
KIAA0941Rev(+EcoRI) primers and the Kazusa construct as template. The A-tailed 
product was ligated into the pGEM-T vector (Promega), from which it was digested 
with EcoRI and subcloned into the EcoRI sites of pGADGH, pcDNA3.1HisB, and 
pEGFP-C1. The GFP-0941CT vector was constructed by digesting the parent vector 
with PstI, and ligating the resulting fragment into the PstI site of pEGFP-C1. The 
backbone was purified and religated to give the GFP-0941NT vector. The 
KIAA0941CT 6XHis-fusion vector was constructed by ligating the HindIII fragment, 
coding for amino acids 276-511, into the HindIII site of pTrcHisA. The backbone 
from this digestion was relegated to produce pTrcHisA KIAA0941NT (codes amino 
acids 1-275). The EcoRI/SalI fragment from this vector was subcloned into the same 
sites in pGADGH to give pGADGH KIAA0941NT, and the EcoRI fragment from 
pEGFP-C1 KIAA0941CT was subcloned into the EcoRI site of pGADGH to give 
pGADGH KIAA0941CT.   
 
Primer Primer Sequence Tm 
RCPFwd 5’-CGGGATCCCGCAGAAGACGCATGGTATAAG-3’ 60 
GSP6 5’-CGGGATCCGCCCTGGATCTAAGCAGAAGGTATT-3’ 63 
KIAA0941Fwd 5’-CGGAATTCCCTGTCCGAGCAAGCCCAAAAG-3’ 58 
KIAA0941Rev 5’-CGGAATTCGAAACCAGCCACAGGATCAATTC-3’ 56 
Rab11I44E 5’-TGCAAACTCTACTCCCTCGGTGCTCTT-3’ 63 
 
Table 1. Primer sequences. Introduced restriction sites indicated in bold. 
Oligonucleotides were supplied by Genset.  
 
2.3.2 Plasmid Quickscreen 
 
25l of overnight E.coli cultures were centrifuged at 9000rpm in a benchtop 
centrifuge (Eppendorf) and resuspended in 50l of 1X Cracking Buffer (700l 2X 
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Cracking Buffer, 420l dH2O, 140l 6X DNA loading dye, 140l glycerol; 2X 
Cracking buffer contains 100mM NaOH, 10mM EDTA pH 8.0, 1% SDS, 10% 
glycerol) and incubated at room temperature for 5 minutes. 15l was then separated 
on a 0.8% agarose gel.  
 
2.3.3 Rapid Amplification of cDNA Ends (RACE) 
 
Each 5’ RACE reaction used 3l of an adaptor-ligated placental cDNA library 
as template, the adaptor primer (AP1, 50pmol), gene-specific primer 3 (GSP3, 
50pmol), 0.2mM dNTPs, 10l 10X Vent Buffer, and 1 unit Vent DNA polymerase 
(New England Biolabs), in a total volume of 100l. The PCR parameters were forty 
cycles of 95oC for 30 seconds, 65oC for 30 seconds, and 72oC for 1 minute. As no 
specific bands were seen, 1l of this reaction was used as template for a nested PCR, 
which used adaptor primer 2 (AP2, 50pmol) and Nested-GSP3 (N-GSP3) as an 
internal gene-specific primer; 
 
.  
Primer Primer Sequence Tm 
AP1 5’-CCATCCTAATACGACTCACTATAGGC-3’ 70 
AP2 5’-ACTCACTATAGGGCTCGAGCGGC-3’ 70 
GSP3 5’-TTGAAGTCGGCAGGACAGACATGGACTGGGAAAGAGG-3’ 76 
NGSP3 5’-GCGGTGTCTGACCCACTGTCCTTATTCTTC-3’ 66 
Table 2. Primers used for the 5' RACE reactions. 
 
The same cycling parameters were used for the nested PCR. The products of 
this reaction were cleaned up using the Geneclean II kit (BIO 101), and A-tailed with 
200M of dATP and 1 unit of Taq, at 72oC for 20 minutes, allowing subsequent 
ligation into a T-vector (pGEM T-Easy, Promega).  
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Figure 7. Overview of 5’-directed RACE procedure 
 
 
2.4 Protein Purification and Production of Antiserum 
 
SDS-polacrylamide gel electrophoresis (PAGE), Western blotting, and 
Coomassie Blue gel staining, were performed using standard techniques.  
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2.4.1 Protein Purification 
2.4.1.1 Purification of 6XHis-tagged Proteins 
 
Ten millilitres of LB (1% NaCl, 1% tryptone, 0.5% yeast extract, pH 7) 
containing ampicillin (50g/ml) and chloramphenicol (34g/ml) was innoculated with 
E.coli BL21, containing the appropriate 6XHis-tagged construct, and grown overnight 
at 37oC. This was used to inoculate 1 litre of LB, containing the same concentrations 
of antibiotics. The inoculate was grown to an OD600=O.4-O.5 and expression of the 
his-tagged protein was induced with 0.5mM IPTG (Melford) and the culture was 
incubated for a further 4 to 5 hours. The cells were harvested by centrifugation and 
resuspended in 50mls Purification Buffer (50mM sodium phosphate, pH 8, 300mM 
NaCl, 2mM MgCl2, + protease inhibitors). The suspension was snap-frozen and 
thawed on ice. DNase (5g/ml), RNase (5g/ml), and Triton X-100 (TX-100), to a 
final concentration of 0.1%, was added and incubated rotating at 4oC for 1 hour. The 
lysate was clarified by centrifugation at 12,000g for 20 minutes, at 4oC. Meanwhile, 
5ml of a 50% slurry of Ni2+-agarose (Qiagen) was pre-equilibrated in 10 volumes of 
ice-cold Purification Buffer, 0.1% TX-100, for 30 minutes. The clarified lysate was 
incubated with the pre-equilibrated Ni2+-agarose for 1 hour on a rotating wheel at 4oC. 
The lysate/agarose was centrifuged at 800g, at 4oC, and the Ni2+-agarose was washed 
5 times with 5 volumes of Purification Buffer, containing increasing concentrations of 
imidazole (Sigma) (0mM, 20mM, 40mM, 60mM, and 80mM). The his-tagged protein 
was then eluted by incubating the agarose pellet for 5 minutes in 1 volume of 
Purification Buffer containing 250mM imidazole. The elution step was repeated and 
the eluates were pooled and dialysed extensively against 1X PBS. 
Note:- At each stage of the purification an aliquot was taken for analysis by 
polyacrylamide gel electrophoresis (PAGE). 
 
2.4.1.2 Purification of GST-tagged Proteins 
 
GST-tagged proteins were purified according to the manufacturers protocol 
(Amersham Pharmacia). Briefly, 400mls of LB/Amp was inoculated with 8ml of an 
overnight culture of E.coli, containing the GST-fusion construct. The protein was 
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induced with 0.2mM IPTG once the culture reached an OD600=0.5-0.8, and was 
incubated for a further 4 hours at 37oC. After induction the cells were harvested, 
resuspended in 20ml of PBS, and snap-frozen. Once thawed, the suspension was 
sonicated to lyse the bacteria, and incubated with 1% TX-100 for 30 minutes at 4oC. 
The lysate was clarified by centrifugation at 12,000g, at 4oC. The clarified lysate was 
incubated with 500l of pre-equilabrated glutathione-agarose (Sigma), for 1 hour, 
under rotation at 4oC. The agarose was washed 3 times with 10 volumes of ice-cold 
PBS, and the fusion protein was eluted, at room temperature for 10 minutes, with 1 
volume of elution buffer (10mM reduced-glutathione in 50mM TrisHCl, pH 8.0). The 
elution step was repeated twice more. The pooled elution fractions were extensively 
dialysed against 1X PBS.    
 
2.4.2 Generation of Antiserum 
 
To generate RCP and KIAA0941 antiserum, purified his-tagged protein was 
used to innoculate a New Zealand White rabbit, (Biological Services Unit, U.C.C.). 
The rabbit was given weekly inoculations of the protein (approx. 250g, complexed 
with Freunds’ adjuvant, per injection). After four weeks a test bleed was taken and the 
number of subsequent injections was determined based on the affinity of the serum for 
low amounts (5-10ng) of the purified protein.  
 
2.4.3 Production of Affinity-Purified Antibodies 
 
Approximately 400g of protein was separated on a polyacrylamide gel and 
transferred to nitrocellulose. The protein was revealed with Ponceau S solution and 
the large band corresponding to the polypeptide was cut out. The Ponceau S was 
washed off and the band was blocked for 1 hour with 5% fat-free powdered milk 
(Marvel) dissolved in 1X TBST (10mM Tris pH 8, 150mM NaCl, 0.1% Tween 20). 
After the blocking step the band was then incubated with 4ml of the rabbit serum, 
overnight at 4oC. The band was then washed four times with 1X TBST, and the bound 
antibodies were eluted from the nitrocellulose by incubation with 0.5ml of 0.2M 
glycine (pH 2.15) for 15 minutes. This was then neutralised with 0.2ml K2HPO4. The 
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elution step was repeated once and the eluates pooled and dialysed extensively in 1X 
PBS, in the cold-room. The nitrocellulose was conserved at -20oC. The concentration 
of the affinity-purified antibodies was determined using Bradford reagent. 
 
2.4.4 Subcellular Fractionation 
 
HeLa cells were resuspended in Fractionation Buffer (250mM sucrose, 3mM 
imidazole, plus protease inhibitors) and lysed by freeze-thawing three times, and 
passing through a 26-gauge needle six times. A postnuclear supernatant (PNS) was 
prepared by centrifuging at 10,000g for 10 minutes, at 4oC, in a bench-top refrigerated 
centrifuge. The PNS was then centrifuged at 100,000g for 1 hour at 4oC in a Beckman 
L8-55 (rotor Ty65) ultracentrifuge. The cytosol (supernatant) was removed to a fresh 
tube and the membrane fraction (pellet) was resuspended in an equal volume of 
Fractionation Buffer. To test the stability of RCP on the membrane, the PNS was 
incubated with 1% TX-100, 1M Na2CO3 (pH11), or 1M NaCl, for 30 minutes on ice 
prior to ultracentrifugation.  
 
2.4.5 In vitro Interactions 
2.4.5.1 Radioactive Overlay Method 
 
The protein of interest was separated on an SDS-PAGE gel, and transferred to 
nitrocellulose. The blot was incubated overnight in Renaturation Buffer (50mM 
Hepes, pH7.2, 5mM magnesium acetate, 100mM potassium acetate, 3mM DTT, 
10mg/ml BSA, 0.1% Triton X-100, 0.3% Tween-20). 35g of purified His-
Rab4AQ67L or GST-Rab11Q70L was loaded with [-32P] GTP (specific activity 
800Ci/mmol), at a final concentration of 0.1M, in 20mM Hepes pH 7.2, 4mM EDTA 
and incubated at 37oC for 1 hour. MgCl2 was added to a concentration of 10mM to 
stabilise the nucleotide on the Rab protein. The nucleotide-loaded protein was then 
added to 10ml Binding Buffer (12.5mM Hepes, pH7.2, 1.5mM magnesium acetate, 75 
mM potassium acetate, 1mM DTT, 2mg/ml BSA, 0.05% TX-100, 0.05% CHAPS) 
and incubated with the blot, on a rocking platform for 1 hour 15 minutes, at room 
temperature. The blot was then washed twice for 10 minutes in Wash Buffer (20mM 
 47
Tris-HCl, pH7.4, 100mM NaCl, 20mM MgCl2, 0.005% TX-100) and visualised using 
a phosphor imager (Storm 860, Molecular Dynamics). 
 
2.4.5.2 Far Western Method 
 
The Far Western technique is essentially the same as the radioactive overlay 
technique, with the exception that GST-tagged Rab GTPases were loaded with cold 
GTPS. The incubation and washes of the Rab protein were the same, except the 
bound protein was visualised with a polyclonal anti-GST antibody (Amersham 
Pharmacia), using a standard Western blotting procedure.    
 
2.5 Cell Biology 
2.5.1 Cell Lines and Antibodies 
 
HeLa cells were cultured in Dulbecco’s Modified Eagles Medium (DMEM) 
supplemented with 10% foetal calf serum (FCS), 2mM L-glutamine, 100U/ml 
penicillin and streptomycin, and 25mM Hepes, pH 7.4. The BeWo cell line was 
cultured in HAM’S-F12 supplemented with 10% FCS, 2mM L-glutamine, 25mM 
Hepes, pH 7.4, and 50U/ml penicillin and streptomycin. The HeLa Rab4WTGFP 
stable cell line was cultured the same way as untransfected HeLa cells with the 
exception that the plasmid was maintained with 0.4mg/ml G418, and 20 hours prior to 
an experiment Rab4WTGFP expression was induced with 10mM sodium butyrate. All 
cell lines were grown in a 5% CO2 incubator at 37oC. 
The rabbit antibodies used were the affinity-purified H13p antibody, and used 
at a 1:100 dilution to detect endogenous RCP, and 1:1000 to detect overexpressed 
protein. The Rab11 antibody was a kind gift from Dr. Bruno Goud and used at a 1:150 
dilution. The EEA1 antibody was a gift from Prof. Harald Stenmark, and used at 
1:1000. Monoclonal antibodies used included anti-LBPA, a gift from Prof. Jean 
Greunberg, and used at 1:100. Anti-Express (InVitrogen) was used at 1:2000. The 
transferrin receptor antibody (Roche) for immunofluorescence was used at 1:1000. 
The anti-TfnR antibody for immunoblotting was from Zymed and used at 1:1000. 
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Anti- tubulin (Sigma) used at 1:300. Anti-EEA1 (BD Transduction Laboratories) 
used at 1:1000. 
 
2.5.2 Transfection 
 
Transfection of HeLa cells, for the study of the effects of overexpression of 
H13p, RCP, or KIAA0941, used the T7 RNA polymerase recombinant vaccinia virus 
system. This method resulted in a high level of expression of the recombinant protein. 
Cells were seeded on coverslips in 24-well plates so that they reached a confluency of 
60-70% the next day. They were then infected at a multiplicity of infection (MOI) of 
10 with vaccinia strain MVA T7 polymerase. After 45 minutes the cells were washed 
once with 1X PBS and then transfected with 1.5-3g of plasmid DNA, in serum free 
medium. The plasmid transfection mix was prepared as follows; the plasmid DNA 
was diluted to 20l in HBS (20mM Hepes, pH 7.2, 150mM NaCl). 10l of DOTAP 
(Roche) was mixed with an equal volume of HBS and added to the DNA solution. 
The solution was mixed by pipetting several times. A DOTAP/DNA complex was 
allowed to form by incubating at room temperature for 15 minutes. The DNA/DOTAP 
mixture was then diluted in 200l of DMEM without serum, supplemented with 0.2% 
BSA, and added to the infected cells. The transfections were allowed to proceed for 6-
7 hours.  
In some cases, for colocalisation purposes, Effectene (Qiagen), a non-
liposomal transfection reagent, was used. The manufacturer’s protocol was followed. 
Transfections usually proceeded for 6-8 hours, which gave an expression level 
slightly above that of the endogenous protein.   
 
2.5.3 Immunofluorescence 
 
Cells on 11mm round glass coverslips were fixed with 3% paraformaldehyde. 
Free aldehyde groups were quenched with 50mM NH4Cl. The cells were 
permeablised with 0.05% saponin in 1X PBS, 0.2% BSA, and then incubated in a 
humid chamber with the primary antibodies, for 1 hour. The coverslips were then 
washed with 1X PBS and incubated with secondary antibodies. The secondary 
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antibodies used were Texas Red-coupled donkey anti-rabbit IgG or anti-mouse IgG, 
fluorescein isothiocyanate (FITC)-coupled donkey anti-mouse IgG, and AMCA-
coupled donkey anti-rabbit IgG (Jackson Immunochemicals). All secondary 
antibodies were used at a 1 in 200 dilution. Coverslips were mounted on Mowiol and 
examined on an Eclipse E600 (Nikon) immunofluorescence microscope, or a confocal 
microscope (Zeiss). Note: When the -tubulin antibody was used the cells were fixed 
with -20oC methanol. 
 
2.5.4 Preparation of FITC-Transferrin 
 
FITC-conjugated transferrin was produced by preparing 100l of a 5mg/ml 
solution of holo-transferrin (Sigma), in PBS plus 1mM MgCl2, 1mM CaCl2 (PBS++).  
50l of 1M NaHCO3, pH 8.5, and 150l of a 10mg/ml stock of FITC-Celite 
(Calbiochem) in PBS++, was added and brought to a final volume of 225l with 
PBS++. This was incubated for 30 minutes at room temperature. To stop the reaction 
6.5l of 1M glycine was added. The reaction was centrifuged to remove the Celite, 
and the supernatant was loaded onto a PD-10 column (Pharmacia) that had been 
equilibrated with 50mM Hepes, pH7.25, 100mM NaCl. The supernatant separated 
into two yellow bands and the lower band was collected. 
Note: At all stages the FITC-transferrin was protected from light in amber 1.5ml 
microcentrifuge tubes. 
 
2.5.5 Uptake of FITC-Tfn and Texas-Red EGF in HeLa Cells 
 
HeLa cells were seeded on glass coverslips so that they were approximately 
70% confluent the next day. The cells were washed once with PBS and then starved in 
DMEM lacking serum for at least two hours at 37oC (in order to deplete the cells of 
endogenous transferrin). In cells that had been transfected, prior to ligand uptake, this 
step was omitted, as the transfection medium contained no serum. The coverslips 
were transferred to a humid chamber and incubated at 37oC (5% CO2) with 25g/ml 
of FITC-transferrin in Depletion Media (DMEM, 25mM Hepes pH7.2, 1% BSA) for 
one hour, to load the recycling pathway. In the cases where there was dual ligand 
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uptake, Texas Red-labelled EGF (Molecular Probes) was used at a concentration of 
3g/ml. After the incubation, the cells were washed twice with ice-cold 1X PBS and 
fixed with ice-cold 3% paraformaldehyde. They were then processed for 
immunofluorescence microscopy as described previously. 
For the pulse/chase experiments the transfections were performed in duplicate. 
After transfection, the ligands were internalised at 18oC for 45 minutes. One duplicate 
was washed and immediately fixed, while for the other duplicate, the ligands were 
chased into the cell at 37oC for 10 minutes, prior to fixation. 
 
2.5.6 In Vitro Recycling Assay 
 
The in vitro recycling assays have been described elsewhere (Ullrich et al., 
1996). In brief, BHK cells infected with the modified vaccinia virus were co-
transfected with the human TfnR and the indicated construct. Control cells were 
transfected with the human TfnR alone. 125I-Tfn was allowed to bind to the cell 
surface, on ice for 1 hour. Excess ligand was washed off and the 125I-Tfn was 
internalised for the indicated times. The amount of 125I-Tfn in the culture medium, and 
therefore recycled, was calculated, and expressed as a percentage of total 125I-Tfn (cell 
associated and culture medium 125I-Tfn).  
To measure the kinetics of recycling specifically from the recycling 
compartment, the above protocol was modified. The transfected BHK cells were 
pulsed at 37oC for minutes with 125I-Tfn, excess ligand was washed away, and the 
cells were then chase at 37oC for a further 30 minutes. This allowed the recycling 
compartment to be loaded. The amount of 125I-Tfn in the culture medium at the 
indicated time points, after the chase was calculated and expressed as a percentage of 
the total 125I-Tfn.  
For both assays, the effects on the rate of recycling due to transfection of the 
indicated mutants was compared to the kinetics of the control assay. 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3 Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.1  Rab Coupling Protein 
3.1.1 Yeast Two-Hybrid Screen of an oligo-dT Primed HeLa cDNA 
Library using Rab4Q67L as Bait 
 
Rab4 is a small GTPase implicated in the regulation of transport from the early 
sorting endosome. In contrast to Rab GTPases such as Rab5 and Rab6, relatively little 
is known about Rab4. In order to identify effector proteins for Rab4, a yeast two-
hybrid screen was performed using a constitutively active mutant of Rab4, Rab4Q67L 
(-CXC), as bait (for a complete description refer to the PhD thesis of Alan Hendrick). 
Rab4Q67L has a point mutation in its GTPase domain that results in the reduced 
ability of the mutant to hydrolyse GTP to GDP. An oligo-dT primed HeLa cDNA 
library, which had been used successfully in other yeast two-hybrid assays (Stenmark 
et al., 1995; Cantalupo et al., 2001), was screened with the bait. Saccharomyces 
cerevisiae L40 was transformed with the Rab4Q67L mutant in a vector that expresses 
it as a fusion with the DNA binding domain of the LexA transcription factor, pVJL10 
Rab4Q67L(-CXC). This mutant lacked the CXC prenylation motif, since 
communication with other labs (M.Zerial and H.Stenmark) suggested that the 
presence of the geranyl-geranyl group results in a high background of false-positive 
interactions. Transformants were selected on media lacking tryptophan. Yeast 
containing the bait vector was then transformed with the HeLa cDNA library and 
plated on media lacking tryptophan, leucine, and histidine. Only yeast colonies that 
contain a library clone that interacts with the Rab4Q67L(-CXC) fusion protein, 
allowing the DNA binding domain of the bait and the activation domain fused to the 
prey to come into close proximity and activate transcription of the HIS3 gene, can 
grow on the selective media.  
Approximately 3x106 transformants were screened, of which 44 colonies grew 
on the His- media and activated the -galactosidase reporter gene. Plasmids were 
recovered from these colonies using a plasmid preparation protocol modified for 
yeast, and the library plasmid was selected in the E.coli HB101 strain. To further 
analyse these library clones and identify false-positives they were co-transformed into 
L40 along with Rab4Q67L or lamin. Lamin is a nuclear structural protein that was 
used as a negative control. Lamin is unrelated to Rab4 and therefore any of the library 
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clones that interacted with it were considered to be false-positives. Fourteen library 
clones expressed the lacZ gene specifically with Rab4Q67L. These positive clones 
were sequenced. Five clones encoded Rabaptin-5, a Rab5 effector protein that had 
previously been shown to interact with Rab4 (Vitale et al., 1998). Four clones 
encoded a novel protein that showed no homology with any protein in the databases, 
at the time. The remaining plasmids were only represented once and contained 
unrelated reading frames. 
Clone H13, a member of the second group of clones, was chosen for further 
study. All the clones in this group contained an approximately 3.6kb insert. Digestion 
of clone H13 with EcoRI cut out three insert fragments of just under 1kb, 550bp, and 
approximately 2.1kb, plus the vector backbone that runs at over 7kb;  
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Figure 8. EcoRI digestion of clone H13. Clone H13 digested with EcoRI. The arrow 
indicates the fragment that contains the H13 coding sequence (lane 1). DNA 
molecular weight markers (lane 2). 
 
Sequencing revealed that the 1kb EcoRI fragment contained a 270 amino acid 
reading frame that was expressed ‘in frame’ with the Gal4 activation domain of 
pGADGH (Figure 9). The 550bp fragment contained 3’-untranslated sequence 
followed by a polyA tail. Surprisingly, the 2kb fragment contained a yeast 
transposable element that is likely to have transposed into the cDNA during the 
construction, or screening of the library. To ensure that the interaction with 
Rab4Q67L was not due to the presence of the transposon, the 1kb EcoRI fragment, 
alone, was subcloned into the prey vector, and tested for interaction with Rab4. As 
expected, there was still an interaction with Rab4 (data not shown). 
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     1 - CTTCCACCAAGGACTCCTTGAAGTCTATGACCTTGCCGACCTACCGACCTGCCCCACTGA - 60  
       -   S  T  K  D  S  L  K  S  M  T  L  P  T  Y  R  P  A  P  L  I    
    61 - TCAGTGGGGACCTCAGGGAAAAAATGGCCCCCGCAAACTCAGAGGCCACAAAAGAAGCTA - 120  
       -   S  G  D  L  R  E  K  M  A  P  A  N  S  E  A  T  K  E  A  K    
   121 - AGGAGAGCAAGAAGCCAGAGAGCAGGAGGTCCTCTTTGCTGTCTCTGATGACGGGGAAGA - 180  
       -   E  S  K  K  P  E  S  R  R  S  S  L  L  S  L  M  T  G  K  K    
   181 - AGGATGTGGCTAAGGGCAGTGAAGGTGAAAACCTTCTCACGGTCCCAGGGAGGGAGAAGG - 240  
       -   D  V  A  K  G  S  E  G  E  N  L  L  T  V  P  G  R  E  K  E    
   241 - AAGGCATGCTGATGGGGGTTAAGCCGGGGGAGGACGCATCGGGGCCTGCTGAAGACCTTG - 300  
       -   G  M  L  M  G  V  K  P  G  E  D  A  S  G  P  A  E  D  L  V    
   301 - TGAGAAGATCTGAGAAAGATACTGCAGCTGTTGTCTCCAGACAGGGCAGCTCCCTGAACC - 360  
       -   R  R  S  E  K  D  T  A  A  V  V  S  R  Q  G  S  S  L  N  L    
   361 - TCTTTGAAGATGTGCAGATCACAGAACCAGAAGCTGAGCCAGAGTCCAAGTCTGAACCGA - 420  
       -   F  E  D  V  Q  I  T  E  P  E  A  E  P  E  S  K  S  E  P  R    
   421 - GACCTCCAATTTCCTCTCCGAGGGCTCCCCAGACCAGAGCTGTCAAGCCCCGACTTCATC - 480  
       -   P  P  I  S  S  P  R  A  P  Q  T  R  A  V  K  P  R  L  H  P    
   481 - CTGTGAAGCCAATGAATGCCACGGCCACCAAGGTTGCTAACTGCAGCTTGGGAACTGCCA - 540  
       -   V  K  P  M  N  A  T  A  T  K  V  A  N  C  S  L  G  T  A  T    
   541 - CCATCATCAGTGAGAACTTGAACAATGAGGTCATGATGAAGAAATACAGCCCCTCGGACC - 600  
       -   I  I  S  E  N  L  N  N  E  V  M  M  K  K  Y  S  P  S  D  P    
   601 - CTGCATTTGCATATGCGCAGCTGACCCACGATGAGCTGATTCAGCTGGTCCTCAAACAGA - 660  
       -   A  F  A  Y  A  Q  L  T  H  D  E  L  I  Q  L  V  L  K  Q  K    
   661 - AGGAAACGATAAGCAAGAAGGAGTTCCAGGTCCGCGAGCTGGAAGACTACATTGACAACC - 720  
       -   E  T  I  S  K  K  E  F  Q  V  R  E  L  E  D  Y  I  D  N  L    
   721 - TGCTTGTCAGGGTCATGGAAGAAACCCCCAATATCCTCCGCATCCCGACTCAGGTTGGCA - 780  
       -   L  V  R  V  M  E  E  T  P  N  I  L  R  I  P  T  Q  V  G  K    
   781 - AAAAAGCAGGAAAGATGTAAATCAGCAGAAAAAAAACACCGAGACGTTTCTGTGACTTCA - 840  
       -   K  A  G  K  M  *   
   841 - CTTTCACCTGCTCCAGGGGTCAAGGACTTGCCTTGCCTGATAACCAGCCAGCAGGCTCCG - 900   
   901 - AATCACCATCTCCCTCACATGTTATCCGGCAAGAGTGAATTC - 942  
        
 
Figure 9. DNA sequence and translation of the clone H13 EcoRI fragment that 
contains the reading frame. The downstream EcoRI site is in bold. 
 
3.1.2 Clone H13 Interacts in a Nucleotide-Dependent Manner with 
Rab4 and Rab11 
 
The Rab4 interaction was tested to determine if clone H13 had a preference for 
the nucleotide-bound state of the small GTPase. S. cerevisiae L40 was co-transformed 
with clone H13 and either Rab4Q67L, Rab4WT, Rab4S22N (GDP-locked mutant), or 
a constitutively active form of Rab4 with a mutation in the putative effector domain, 
Rab4Q67L/I41E. Colonies from each transformation plate were spotted in parallel 
onto media containing histidine, and media lacking histidine. There was strong growth 
with Rab4Q67L, slightly less with Rab4WT, and no growth with Rab4S22N, or the 
effector mutant (Figure 10A & 10C). Thus, clone H13 interacts preferentially with the 
active form of Rab4, and this interaction is mediated via the putative ‘effector’ 
domain. To determine if clone H13 interacts exclusively with Rab4, it was tested for 
interactions with the constitutively active mutants of Rab3, Rab5, Rab6 and Rab7. 
There was no interaction with any of these small GTPases (Figure 10C), however, 
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there was a strong interaction with Rab11 (Figure 10B & 10C). The interaction 
between clone H13 and Rab11 did not appear to be nucleotide-dependent and was not 
affected by a mutation in the Rab11 effector domain; 
 
 
    A B
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. Interaction of clone H13 with Rab4, and its mutants (A), or with Rab11, 
and its mutants (B). Growth on media lacking histidine indicates an interaction 
between the ‘bait’ and ‘prey’ fusion proteins. Quantitative -galactosidase assays. 
Clone H13 was co-transformed with the indicated Rab constructs and the -
galactosidase activity of the double transformants was measured using ONPG as 
substrate (C). The Ras/Raf interaction was used as a positive control.     
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The strength of the interactions between clone H13, and Rab4 and its mutants, 
or Rab11 and its mutants, was quantified in a liquid -galactosidase assay (Figure 
10C). An interaction between ‘bait’ and ‘prey’ vectors results in the transcription of 
the HIS3 and lacZ reporter genes. The strength of an interaction can be quantified by 
measuring the -galactosidase activity in a lysate, containing two interacting proteins, 
using o-nitrophenyl--D-galactosidase (ONPG) as substrate. Clone H13 displayed a 
stronger, overall, interaction with all the Rab11 constructs, than it did with 
Rab4Q67L. 
Taken together these results indicate that clone H13 is likely to be a genuine 
Rab4 interacting polypeptide, and its preference for the GTP-bound form of Rab4 fits 
the conventional model of a Rab effector. The interaction with Rab11 is also likely to 
be of importance, despite the somewhat different interaction pattern, as clone H13 
does not interact with other closely related Rab GTPases, ruling out the possibility 
that it is just a ‘sticky’ protein. Even though the interaction with Rab11 was 
unexpected, it is not unprecedented. Rabaptin-5 interacts with both Rab5 and Rab4 
(Vitale et al., 1998). Since Rab4 functions upstream of Rab11 along the receptor 
recycling pathway, it is possible that clone H13 represents a protein that acts as an 
intermediate between a Rab4-regulated transport event and a Rab11-regulated 
transport event. 
 
3.1.2.1 Generation of a Rab11 Effector Domain Mutant 
 
The yeast two-hybrid Rab11 wild-type, and mutant, constructs were a kind gift 
from Ms. Francesca Senic-Matuglia and Dr Bruno Goud. However, since a Rab11 
effector domain mutant was not available, it was necessary to generate this mutant, by 
two step site-directed mutagenesis. The effector domains of Rab proteins are located 
within their ‘switch’ regions (Stenmark et al., 2001). The corresponding mutation to 
the Rab4I41E mutant was introduced into Rab11;  
 
 
 
 
Figure 11. ClustalW alignment of the effector domains of Rab4, Rab11, and Rab6. 
The arrow indicates the position of the isoleucine to be mutated. 
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The isoleucine at position 44 was to be mutated to a glutamic acid residue. The 
constitutively active mutant, Rab11Q70L, was used as template for the reaction. The 
first round PCR contained the mutagenic primer and an upstream vector based primer. 
The 150bp product of this reaction was used as the upstream primer in the second 
round PCR; 
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Figure 12. Generation of the Rab11Q70L/I44E mutant. (1) 1st-round PCR product; 
(2) 2nd-round PCR product. 
 
The second-round product was digested and ligated into the yeast two-hybrid 
bait vector, pLexA. The introduction of the point mutation, and the absence of other 
mutations introduced during the PCR process, was confirmed by sequencing (Dept. 
Biochemistry, University of Oxford). 
 
3.1.3 Expression and Purification of Clone H13 Protein 
 
To perform biochemical studies, and to raise antibodies, it was necessary to 
express and purify H13 polypeptide (H13p). To this end, the 1kb fragment containing 
the H13 reading frame was subcloned into a prokaryotic expression vector, pTrcHisC 
(Invitrogen). This vector adds an amino-terminal epitope containing six consecutive 
histidine residues to the protein of interest. The 6XHis-tag has a high affinity for 
nickel. This allows for the purification of the fusion protein from a bacterial cell lysate 
using Ni2+-chelated agarose. The 6XHis-tag has a low antigenicity making it an ideal 
tag for the production of protein that will be used for generating antiserum. 
Expression of 6XHis-H13p in E.coli BL21 was induced with 0.2mM IPTG. Five 
hours post-induction a bacterial cell lysate was prepared and incubated with Ni2+-
agarose. After several washes the bound protein was eluted with a high concentration 
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of imidazole. This system allowed for the purification of sufficiently pure H13 fusion 
polypeptide to inoculate a rabbit and use for biochemical studies. The H13 fusion 
construct expressed a 37kDa protein that was used to inoculate a New Zealand White 
rabbit, and the resulting affinity purified antibodies could detect as little as 5ng of 
purified H13p by Western blot; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13. A. Coomassie blue gel of the steps involved in the purification of 6XHis- 
H13p, B. Western blot showing the detection limits of the H13p affinity-purified 
antibody. 
 
The 6XHis-tag allowed for the relatively rapid and simple purification of large 
quantities of pure H13p. The resulting H13p antiserum was useful for detecting 
overexpressed H13p, however, to detect the endogenous protein by immunoblot or 
immunofluorescence it was necessary to affinity purify the serum. Analysis revealed 
that it was specific for H13p since it did not recognise the 6XHis tag of other proteins 
(data not shown).  
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3.1.4 H13p Antiserum Detects a Ubiquitously Expressed 80kDa 
Protein 
 
To determine the size and expression pattern of endogenous H13p, affinity 
purified H13p antibody was used to probe the post-nuclear supernatants (PNS) of 
various tissue culture cell lines. The antibody detected a single band that migrated at 
approximately 80kDa, in all the cell lines tested; 
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Figure 14. Affinity purified H13p antibody detects an 80kDa protein expressed in 
BeWo (placental trophoblastic choriocarcinoma) cells, HL60 (promyelocytic 
monocyte) cells, A431 (epidermoid carcinoma) cells, and HeLa (cervical carcinoma) 
cells 
 
This result indicates that clone H13 is only a partial clone. The method of 
construction of the two-hybrid library, i.e. oligo-dT primed, and the presence of the 
polyA-tail in the H13 cDNA, indicates that H13 represents the carboxy-terminal 
portion of a full-length protein. The full-length 80kDa protein was named Rab 
Coupling Protein (RCP), since it interacts with two Rab GTPases, which play 
sequential roles in the receptor recycling pathway. (See the next section for a 
description of the cloning of the full-length cDNA). RCP appears to be expressed in 
most tissues indicating that it plays an important general role along the receptor 
recycling pathway rather than a tissue-specific role. 
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3.1.5 Generation of the Full-Length RCP cDNA 
  
Since the H13 fusion construct codes for an approximately 37kDa protein, it 
was apparent that it represents only a portion of the full-length RCP gene. In order to 
clone the full-length RCP cDNA a number of avenues were followed. These included 
searching the expressed sequence tag (EST) databases, screening a  cDNA library, 
using the rapid amplification of cDNA ends (RACE) PCR-based method, and finally a 
bioinformatic approach, that eventually identified the full-length cDNA. Initially, 
searching the EST databases with the H13 cDNA sequence revealed several 
homologous EST clones. One of these, IMAGE Clone 150706, contained an insert 
cDNA that encompassed the entire H13 sequence and approximately 1kb of upstream 
sequence, which included a potential ATG start codon at the 5’-end. There were no 
other ESTs in the databases that provided any further 5’ sequence. The reading-frame 
of IMAGE 150706 was amplified using a proof-reading DNA polymerase and cloned 
into the pGADGH two hybrid ‘prey’ vector. Two-hybrid analysis showed that it 
interacted with both Rab4 and Rab11. The cDNA was then cloned into the 
pcDNA3.1HisB vector and expressed in HeLa cells. The exogenous protein displayed 
a similar distribution to endogenous RCP, and was detectable by the H13p affinity 
purified antibody (data not shown). However, when a postnuclear supernatant (PNS) 
was prepared from HeLa cells expressing the EST cDNA, there was a discrepancy in 
the size of the recombinant protein compared with that of endogenous RCP. The 
recombinant protein migrated slightly lower than endogenous RCP suggesting that the 
EST was missing the extreme 5’-end of RCP. The cDNA cloned from this EST was 
thus designated RCP, reflecting the fact that it was an incomplete cDNA. 
To clone the full-length RCP cDNA it was initially decided to use the RACE 
technique as this approach could potentially deliver the RCP 5’-end in a short time. 
Since we estimated that we were missing no more than 300bp of coding sequence, the 
PCR reactions would not have the added complication of requiring large products to 
be amplified. An adaptor-ligated placental cDNA library was generated from BeWo 
mRNA (courtesy of Alan Hendrick), using the Marathon-Ready cDNA kit (Clontech). 
This library consisted of cDNAs with short adaptor sequences ligated to their 5’- and 
3’- ends. A primer that binds to the adaptor, used in conjunction with a primer that is 
specific for the gene of interest, should allow the amplification of a 5’- product or a 
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3’- product, depending on the direction of the gene-specific primer (see schematic in 
Materials & Methods). Gene-specific primers were designed close to the 5’-end of the 
known, RCP, sequence and were used in 5’RACE reactions. However, despite 
numerous conditions, annealing temperatures, cycle numbers, nested PCRs, Mg2+ 
concentrations, no product was amplified that provided sequence upstream of the 
sequence that was already cloned in RCP. Several times 5’RACE products were 
amplified and sequenced that contained no more than 10bp of upstream sequence. 
Since the RACE technique was unsuccessful a 5’-STRETCH  HeLa cDNA library 
(Clontech) was purchased and a conventional phage library screen was performed 
using radiolabeled H13 cDNA as a probe. This library was constructed in such a way 
that there was a bias towards full-length inserts. Two positive plaques were identified, 
from which the phage were rescued and their inserts analysed. However, while they 
contained the entire H13 cDNA they did not provide the 5’-end of RCP. 
Meanwhile, two major pieces of work were made public that finally allowed 
the identification of the full-length RCP gene. The complete human genome sequence 
was released (Lander et al., 2001; Venter et al., 2001), and the RIKEN Mouse Gene 
Encyclopaedia Project reported the characterisation of a set of 21,076 full-length 
mouse cDNAs (Kawai et al., 2001). The RCP sequence was used in a ‘BLAST’ 
search of the consensus human genome sequence and the results revealed that the 
RCP gene was present on the short arm of chromosome 8, 8p11.2, and was divided 
into at least four exons. However, it was not possible to identify the missing upstream 
coding sequence. Searching the RIKEN database with the RCP sequence identified a 
mouse transcript, AK014696, which was highly homologous to RCP. The mouse 
transcript contained an ORF that coded for a 645 amino acid protein that displayed 
80% homology (and 8% similarity) with RCPp (Figure 17). It was concluded that 
AK014696 was the mouse homologue of RCP, and was designated mRCP. mRCP 
contained 269bp of coding sequence, and a Kozak’s consensus sequence, upstream 
from the beginning of the RCP sequence. This 269bp mRCP sequence, when used to 
search the human chromosome 8 sequence, identified the first exon of human RCP. 
Thus, from this bioinformatic approach it was possible to determine the full-length 
RCP coding sequence. Fortunately, an EST recently deposited in the IMAGE 
databank, IMAGE Clone 3956619, contained the previously unidentified 5’-sequence. 
This EST was requested and sequenced. It contained a large 4.5kb insert and coded 
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for the entire RCP open reading frame (Figure 15). The reading frame was subcloned 
into the pGEM1 vector and expressed in HeLa cells using the vaccinia system. 
Comparison of the molecular weights of the endogenous RCP and recombinant RCP 
revealed that they migrated at the same molecular weight (Figure 16).  RCP is 
comprised of 5 exons at locus 8p11.2. One of the difficulties in identifying the 5’-end 
sequence was that it is coded by a single exon located over 100kb upstream from the 
second exon.  
As a footnote to this section, analysis of the RCP sequence identified a NotI 
restriction site just upstream of the start of the RCP sequence. This could explain the 
difficulty in cloning the full-length RCP cDNA from the RACE library and the  
HeLa cDNA library. NotI is commonly used in the construction of libraries, and in 
this case its use would inadvertently cut off the 5’end of the cDNA. 
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       1 - CCCGCTTCTGGAGTGTTATCGTCACCATGTCCCTAATGGTCTCGGCTGGCCGGGGCCTGG - 60  
       -                           M  S  L  M  V  S  A  G  R  G  L  G    
    61 - GGGCCGTGTGGTCCCCAACCCACGTGCAGGTGACGGTGCTGCAGGCGCGGGGCCTGCGGG - 120  
       -   A  V  W  S  P  T  H  V  Q  V  T  V  L  Q  A  R  G  L  R  A    
   121 - CCAAGGGCCCCGGGGGCACGAGCGACGCGTACGCGGTGATCCAGGTGGGCAAGGAGAAGT - 180  
       -   K  G  P  G  G  T  S  D  A  Y  A  V  I  Q  V  G  K  E  K  Y    
   181 - ACGCCACCTCCGTGTCGGAGCGCAGCCTGGGCGCGCCCGTGTGGCGCGAGGAGGCCACCT - 240  
       -   A  T  S  V  S  E  R  S  L  G  A  P  V  W  R  E  E  A  T  F    
   241 - TCGAGCTGCCATCGCTGCTGTCCTCCGGACCCGCGGCCGCCGCCACCCTGCAGCTCACCG - 300  
       -   E  L  P  S  L  L  S  S  G  P  A  A  A  A  T  L  Q  L  T  V    
   301 - TGCTGCACCGCGCGCTGCTCGGCCTCGACAAGTTCCTGGGCCGCGCCGAGGTGGACCTGC - 360  
       -   L  H  R  A  L  L  G  L  D  K  F  L  G  R  A  E  V  D  L  R    
   361 - GGGATCTGCACCGCGACCAGGGCCGCAGGAAGACGCAGTGGTATAAGTTGAAATCCAAAC - 420  
       -   D  L  H  R  D  Q  G  R  R  K  T  Q  W  Y  K  L  K  S  K  P    
   421 - CAGGAAAGAAGGACAAGGAGCGAGGAGAAATTGAGGTTGACATCCAGTTTATGAGAAACA - 480  
       -   G  K  K  D  K  E  R  G  E  I  E  V  D  I  Q  F  M  R  N  N    
   481 - ACATGACTGCCAGCATGTTTGACCTTTCTATGAAAGACAAGTCTCGGAATCCATTTGGAA - 540  
       -   M  T  A  S  M  F  D  L  S  M  K  D  K  S  R  N  P  F  G  K    
   541 - AGCTGAAGGACAAGATCAAGGGGAAGAATAAGGACAGTGGGTCAGACACCGCCTCCGCCA - 600  
       -   L  K  D  K  I  K  G  K  N  K  D  S  G  S  D  T  A  S  A  I    
   601 - TCATCCCTAGCACGACACCTTCGGTCGACAGTGATGATGAGTCTGTGGTTAAAGACAAGA - 660  
       -   I  P  S  T  T  P  S  V  D  S  D  D  E  S  V  V  K  D  K  K    
   661 - AAAAGAAATCAAAGATCAAGACCTTACTTTCCAAGTCAAATTTGCAGAAGACGCCTCTTT - 720  
       -   K  K  S  K  I  K  T  L  L  S  K  S  N  L  Q  K  T  P  L  S    
   721 - CCCAGTCCATGTCTGTCCTGCCGACTTCAAAGCCAGAAAAAGTGCTGCTTCGTCCCGGAG - 780  
       -   Q  S  M  S  V  L  P  T  S  K  P  E  K  V  L  L  R  P  G  D    
   781 - ACTTTCAGTCCCAGTGGGATGAAGATGACAATGAGGATGAGTCCTCCTCGGCCTCGGATG - 840  
       -   F  Q  S  Q  W  D  E  D  D  N  E  D  E  S  S  S  A  S  D  V    
   841 - TCATGTCTCACAAGAGAACAGCGAGTACGGATCTTAAGCAACTGAACCAGGTCAACTTTA - 900  
       -   M  S  H  K  R  T  A  S  T  D  L  K  Q  L  N  Q  V  N  F  T    
   901 - CCCTTCCCAAGAAGGAAGGACTTTCCTTTCTTGGTGGCCTTCGGTCTAAGAATGATGTCC - 960  
       -   L  P  K  K  E  G  L  S  F  L  G  G  L  R  S  K  N  D  V  L    
   961 - TTTCCCGCTCTAATGTCTGCATCAATGGGAACCATGTTTACCTGGAGCAGCCCCAACCCA - 1020  
       -   S  R  S  N  V  C  I  N  G  N  H  V  Y  L  E  Q  P  Q  P  T    
  1021 - CCGGTGAGATCAAGGATAGCAGCCCGTCCTCCTCCCCATCCCCCAAGGGTTTCAGAAAGA - 1080  
       -   G  E  I  K  D  S  S  P  S  S  S  P  S  P  K  G  F  R  K  K    
  1081 - AAACATTGTTCTCTTCTACAGAGAACCTGGCGGCTGGGTCTTGGAAGGAGCCTGCTGAAG - 1140  
       -   T  L  F  S  S  T  E  N  L  A  A  G  S  W  K  E  P  A  E  G    
  1141 - GAGGTGGGCTGTCTACTGACAGGGATGTCTCCGAATCTTCCACCAAGGACTCCTTGAAGT - 1200  
       -   G  G  L  S  T  D  R  D  V  S  E  S  S  T  K  D  S  L  K  S    
  1201 - CTATGACCTTGCCGACCTACCGACCTGCCCCACTGATCAGTGGGGACCTCAGGGAAAAAA - 1260  
       -   M  T  L  P  T  Y  R  P  A  P  L  I  S  G  D  L  R  E  K  M    
  1261 - TGGCCCCCGCAAACTCAGAGGCCACAAAAGAAGCTAAGGAGAGCAAGAAGCCAGAGAGCA - 1320  
       -   A  P  A  N  S  E  A  T  K  E  A  K  E  S  K  K  P  E  S  R    
  1321 - GGAGGTCCTCTTTGCTGTCTCTGATGACGGGGAAGAAGGATGTGGCTAAGGGCAGTGAAG - 1380  
       -   R  S  S  L  L  S  L  M  T  G  K  K  D  V  A  K  G  S  E  G    
  1381 - GTGAAAACCTTCTCACGGTCCCAGGGAGGGAGAAGGAAGGCATGCTGATGGGGGTTAAGC - 1440  
       -   E  N  L  L  T  V  P  G  R  E  K  E  G  M  L  M  G  V  K  P    
  1441 - CGGGGGAGGACGCATCGGGGCCTGCTGAAGACCTTGTGAGAAGATCTGAGAAAGATACTG - 1500  
       -   G  E  D  A  S  G  P  A  E  D  L  V  R  R  S  E  K  D  T  A    
  1501 - CAGCTGTTGTCTCCAGACAGGGCAGCTCCCTGAACCTCTTTGAAGATGTGCAGATCACAG - 1560  
       -   A  V  V  S  R  Q  G  S  S  L  N  L  F  E  D  V  Q  I  T  E    
  1561 - AACCAGAAGCTGAGCCAGAGTCCAAGTCTGAACCGAGACCTCCAATTTCCTCTCCGAGGG - 1620  
       -   P  E  A  E  P  E  S  K  S  E  P  R  P  P  I  S  S  P  R  A    
  1621 - CTCCCCAGACCAGAGCTGTCAAGCCCCGACTTCATCCTGTGAAGCCAATGAATGCCACGG - 1680  
       -   P  Q  T  R  A  V  K  P  R  L  H  P  V  K  P  M  N  A  T  A    
  1681 - CCACCAAGGTTGCTAACTGCAGCTTGGGAACTGCCACCATCATCAGTGAGAACTTGAACA - 1740  
       -   T  K  V  A  N  C  S  L  G  T  A  T  I  I  S  E  N  L  N  N    
  1741 - ATGAGGTCATGATGAAGAAATACAGCCCCTCGGACCCTGCATTTGCATATGCGCAGCTGA - 1800  
       -   E  V  M  M  K  K  Y  S  P  S  D  P  A  F  A  Y  A  Q  L  T    
  1801 - CCCACGATGAGCTGATTCAGCTGGTCCTCAAACAGAAGGAAACGATAAGCAAGAAGGAGT - 1860  
       -   H  D  E  L  I  Q  L  V  L  K  Q  K  E  T  I  S  K  K  E  F    
  1861 - TCCAGGTCCGCGAGCTGGAAGACTACATTGACAACCTGCTTGTCAGGGTCATGGAAGAAA - 1920  
       -   Q  V  R  E  L  E  D  Y  I  D  N  L  L  V  R  V  M  E  E  T    
  1921 - CCCCCAATATCCTCCGCATCCCGACTCAGGTTGGCAAAAAAGCAGGAAAGATGTAAATCA - 1980  
       -   P  N  I  L  R  I  P  T  Q  V  G  K  K  A  G  K  M  *   
  1981 - GCAGAAAAAAAACACCGAGACGTTTCTGTGACTTCACTTTCACCTGCTCCAGGGGTCAAG - 2040   
  2041 - GACTTGCCTTGCCTGATAACCAGCCAGCAGGCTCCGAATCACCATCTCCCTCACATGTTA - 2100   
  2101 - TCCGGCAAGAGTGAATTCTACCAATGGAAGCCAGGTTAATGATTACAATTAATCTTTTAC - 2160   
  2161 - TGTACATTCCCAAGGCTTTAGTTTTAAATGCCACTGTGCCTTTAACAAGGTTGTAAATAT - 2220   
  2221 - TTTATGCCCACCAGAGATGTGGTCATAAGATCTGATCCTGAGCCAGAGATTCAGATGGCA - 2280   
  2281 - CAGGAAGTATTCATGTATTTTAACACTGGGGTTTTCTTTCTTTCATACTGAGATTTTTTT - 2340   
  2341 - TCAGTATGTATCCTCCAGCTCTTAAAGCTTACCTGAGAAAGCTTTAAATGAGAAAAGGAC - 2400   
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  2401 - CATGCGATTGGTGCTGTGTTACATACACATACTTTCTTGGCTTCTGAGTAGCTCAGGTGT - 2460   
  2461 - GGCTTTTGGCTGCAGATGTTAAATTTTGATACCATGTAAACCTACCCAGCTTCTCAGACT - 2520   
  2521 - TGGGTCTTGTTTTTTGATGGGAACAGAGGTGTTTAGAGAAAGCCTCTGAGTATGCCTTTC - 2580   
  2581 - AGATTTTGAACAAGCGGCCTTTTCTAAACATCGACTTCTACTACTCTCTAGCCTTAAAAT - 2640   
  2641 - ACCTTCTGCTTAGATCCAGGGCCCTTCTACTGGAGATAGGAAAAGTAGAATTCAGGAATT - 2700  
  2701 - AAAAGAATTACTCTTTATTCAATTTGAGGAACTTGGTGAAAGCCCCTCCTCTTATGACAG - 2760   
  2761 - CCAGGTTCCTGCTGGCTAGACCAGCCTATTCAGCGCTTTGCTAGGGGATTGGGTGGTCCA - 2820   
  2821 - CGCACTCGCTAATACAGTTCTCCAGGTGTGGAATGATGTCAATACGATTGCTTGGCCTTT - 2880   
  2881 - TCCCCCTGTGCCTTTGCTCGGTGCTCTGGTTTCCTCAGCAACACTCCTTGTAAGGGGCAG - 2940   
  2941 - AGACAGGGTCCACCAACTCCCCCAAGATGAAGAAGCCCCTTTCAGGCCAGTCTGTGGTGG - 3000   
  3001 - CTCATGCCTGTAACTCCCAGCACTTTGCAAGGCCGAGGAGGGTGGATCACTTGAGGTCAG - 3060   
  3061 - GAGTTCGAGACCAGCCTGACCAACATGGCGAAACCCCATCTCTACTAAAAATACAAAAAT - 3120   
  3121 - TAGCTTGGCATGGTGGTGCGTGCCTGTAATCCCAGCTACTCGGGAGGCTGGGGCAGGAGA - 3180   
  3181 - ATTGCTTGAACTTGGGAGATGGAGGCTGCAGCGAGCCAAGATCGTGCCACTGCACTCCAG - 3240   
  3241 - CCTGGGCAAGAGTTTTTTTAAGACTCTTAAAAAAAGAGCCTGGGCAATTTTTTTAAGACT - 3300   
  3301 - CTGTCTTAAAAAAAAAAAAAAAAAAAAAAAAACTCGACCTGCAGCATGCAAGC - 3353  
 
 
Figure 15. Sequence and translation of the full-length RCP cDNA. The polyA tail is 
underlined. 
 
 
 1           2 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16.  Recombinant RCP migrates at the same molecular weight as endogenous 
RCP. A postnuclear supernatant from HeLa cells transfected with pGEM1 RCP (lane 
2) was run beside a PNS from nontransfected HeLa cells (lane 1), and probed with -
H13 antibody. 
 65
 
   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
hRCP
mRCP
M S L M V S A G R G L G A V W S P T H V Q V T V L Q A R G L R A K G P G G T S D A Y A V I
M S L A A S A G R G P G T M W S P T H V Q V T V L Q A R G L R A K G P G G T S D A Y A V I
hRCP
mRCP
Q V G K E K Y A T S V S E R S L G A P V W R E E A T F E L P S L L S S G - - P A A A A T L
Q V G K E K Y A T S V S E R T L G A P V W R E E A T F E L P P L L S S G A A P A A A A T L
hRCP
mRCP
Q L T V L H R A L L G L D K F L G R A E V D L R D L H R D Q G R R K T Q W Y K L K S K P G
Q L T V L H R A L L G L D K F L G R A E V D L R E L H R D Q G R R K K Q W Y T L K S K P G
hRCP
mRCP
K K D K E R G E I E V D I Q F M R N N M T A S M F D L S M K D K S R N P F G K L K D K I K
K K D K E R G E I E V D I Q F M R N N M T A S M F D L S M K D K S R N P F G K L K D K I K
hRCP
mRCP
G K N K D S G S D T A S A I I P S T T P S V D S D D E S V V K D K K K K S K I K T L L S K
G K N K D S A S D T A S A I V P S V T P S V D S D D E S F S K D K K K K S K I K T L F S K
hRCP
mRCP
S N L Q K T P L S Q S M S V L P T S K P E K V L L R P G D F Q S Q W D E D D N E D E S S S
S S L Q K T P L S Q S M S V L P T S K S D K V L L R A G D F Q S Q W D D D A H E D E S S S
hRCP
mRCP
A S D V M S H K R T A S T D L K Q L N Q V N F T L P K K E G L S F L G G L R S K N D V L S
A S D V M S H K R T S S T D - Q Q P N Q S N F S L P K K E G L S F L G G L R S K N D S L S
hRCP
mRCP
R S N V C I N G N H V Y L E Q P Q P T G E I K D S S P S S S P S P K G F R K K T L F S S T
R S T V C I N G N H V Y M E Q P E A R S E I R E S S P S N S P S P Q G F R R K H L F S S T
hRCP
mRCP
E N L A A G S W K E P A E G G G L S T D R D V S E S S T K D S L K S M T L P T Y R P A P L
E N L A A R S P K E P G E G G G T S S D R R L S D S S T K D S M K S M S L P S Y R - - P L
hRCP
mRCP
I S G D L R E K M A P A N S E A T K E A K E S K K P E S R R S S L L S L M T G K K D V A K
T S G D N R E S M S P A N V E A A R E T K D S K K Q E S K K S S L L S L V T G K R D A A A
hRCP
mRCP
- G S E G E N L L T V P G R E K E - - G M L M G V K P G E D A S G P A E D L V R R S E K D
K G S E S E P L P T V S E K E K E R K G A L V E A Q L R E - - - - - - E D L M R R P E K D
hRCP
mRCP
T A A V V S R Q G S S L N L F E D V Q I T E P E A E P E S K S E P R P P I S S P R A P Q T
A L P V A S Q W G S S L N P F E D V Q I S D P G A T T E S R S E P K P P V P A A R V P Q T
hRCP
mRCP
R A V K P R L H P V K P M N A T A T K V A N C S L G T A T I I S E N L N N E V M M K K Y S
K A V K P R P H P V K P M N T T A T K I A N S S L G T A T I I T E N L I S E A L M K K Y Q
hRCP
mRCP
P S D P A F A Y A Q L T H D E L I Q L V L K Q K E T I S K K E F Q V R E L E D Y I D N L L
P S D P A F A Y A Q L T H D E L I Q L V L K Q K E T I S K K E F Q V R E L E D Y I D N L L
hRCP
mRCP
V R V M E E T P N I L R I P T Q V G K K A G K M
V R V M E E T P N I L R V P A Q M G K K A G K M
 
Figure 17. ClustalW alignment of mRCP (AK014696) v. human RCP (hRCP). 
Identities are highlighted in dark grey, and similarities in light grey.   
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3.1.6 Analysis of the RCP Amino Acid Sequence 
 
RCP is a 649 amino acid protein, with a predicted molecular weight of 70kDa. 
The discrepancy between this and the observed molecular weight, of approximately 
80kDa, may be due to posttranslational modifications. The RCP primary sequence 
was used to search a number of databases (Pfam and Prosite). Searching for motifs 
revealed that it has a C2-domain at its amino-terminus (amino acids 20-122). C2-
domains are involved in mediating the binding of proteins to phospholipids. There are 
two types of C2-domains, calcium-dependent in which binding to phospholipids is 
regulated by Ca2+, and calcium-independent (Rizo and Sudhof, 1998). Most proteins 
that contain these domains are involved in either signal transduction e.g. PKC and 
Ras-GAP, or membrane traffic e.g. Rabphilin-3 and the synaptotagmins, or both. 
There are a number of putative phosphorylation and glycosylation sites throughout the 
sequence.  Secondary structure analysis revealed that RCP has a high probability of 
forming two coiled-coil domains, one near the amino-terminus and one at the 
carboxy-terminus (Lupas, 1997); 
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Figure 18. RCP has a high probability of forming two coiled-coil domains. The x-axis 
indicates the amino acid position, and the y-axis shows the probability of forming a 
coiled-coil (0-1). 
 
Coiled-coil domains are bundles of -helices that wind into a superhelix. They are 
involved in protein-protein interactions. Coiled-coils are also a common feature in 
proteins that form homodimers. 
Using the RCP amino acid sequence in a ‘BLAST’ search of the GenBank 
non-redundant database revealed that it has two close human homologues, KIAA0857 
and KIAA0941 (Figure 19). The cDNAs for these two proteins were cloned at the 
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Kazusa DNA Research Institute as part of a project to clone unidentified human 
cDNAs with the potential of coding for large proteins (Nagase et al., 1998). These two 
proteins shared a high degree of homology with RCP at their amino- and carboxy- 
termini. They both contained an amino-terminal C2 domain, and a carboxy-terminal 
coiled-coil domain. KIAA0857 has since been reported in the literature as pp75, a 
phosphoprotein that may be involved in lupus erythematosus (Wang et al., 1999). A 
subsequent independent study identified KIAA0857 as a Rab11 interacting protein 
involved in the regulation of apical membrane trafficking in polarised epithelial cells, 
and renamed it Rip11 (Prekeris et al., 2000). Work on KIAA0941 has revealed that it 
also interacts with Rab11 (see Section 3.2). These three proteins are, therefore, 
members of a family of Rab11 interacting proteins. RCP is unique in that it also 
interacts with Rab4. There are a number of more distant relatives (see Discussion), 
including KIAA0665 (Hales et al., 2001; Prekeris et al., 2001) and KIAA1821 
(personal communication, Alan Hendrick & Deborah Wallace), both of which also 
interact with Rab11 but not with Rab4. Drosophila melanogaster has one member of 
this family, CG6066, which appears to be the progenitor of RCP, Rip11, and 
KIAA0941. The Drosophila phosphoprotein, Nuf1, may be the progenitor of 
KIAA0665 and KIAA1821 (Rothwell et al., 1998). 
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Figure 19. ClustalW alignment of hRCP, KIAA0941, and Rip11. Identities are 
highlighted in dark grey and similarities are in light grey.  
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This alignment reveals that the three human members of this family share 
highly homologous amino-termini, which encompass their C2-domains. Their 
carboxy-termini also show significant homology, they all have the potential to form a 
coiled-coil. Yeast two-hybrid analysis has shown that the carboxy-terminus mediates 
the interaction with their Rab partner/s. These two domains are separated by a less 
conserved, intervening region. It is likely that the two conserved domains are 
important in mediating the RCP-family cellular functions. 
To further analyse the expression pattern of RCP, a gene expression panel 
(Origene) was analysed. The expression panel consisted of the first strand cDNA from 
various human tissues. These cDNAs were used as the template in PCR reactions with 
internal RCP gene-specific primers (GSP-1 and GSP-2). If RCP is expressed in the 
tissues a band of the appropriate size will be seen when the PCR is separated on an 
agarose gel; 
 
MW  -ve    1       2      3      4       5       6       7       8    +ve   MW   
 
-1018 
 
-517 
-344 
 
 
 
 
 
Figure 20. PCR analysis of a human gene expression panel with RCP gene-specific 
primers. MW. size markers; -ve. negative control 1. brain; 2. heart; 3. testis; 4. lung; 
5. spleen; 6. ovary; 7. small intestine; 8. liver; +ve. positive control. 
 
A 435bp product was amplified in all the tissues tested, which corresponds 
with the product amplified when the clone H13 plasmid was used as template, in the 
positive control reaction. The negative control contained a complete PCR reaction, but 
lacked template.  
 
3.1.7 RCP is a Predominantly Membrane-Bound Protein 
 
 Since Rab proteins cycle between membranes and the cytosol, the RCP/Rab 
interaction may occur in the cytosol, or on endosomes. To determine the subcellular 
localisation of RCP, postnuclear supernatant, a cytoslic fraction (100,000g 
supernatant), and a membrane fraction (100,000g pellet), from HeLa cells was probed 
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with the affinity-purified H13p antibody. RCP was found predominantly in the 
membrane fraction; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. RCP is a membrane bound protein. Western blot using H13p antibody to 
probe a total protein fraction, PNS, cytosol, and membrane extracts from HeLa cells. 
 
When this initial fractionation was performed, no other Rab effector proteins 
had been identified that were predominantly membrane-bound. The conventional idea 
of a Rab effector is of a cytosolic protein that is recruited to the membranes via its 
activated Rab. Rabaptin-5 and Rabphilin-3 are examples of such proteins (Shirataki et 
al., 1993; Stenmark et al., 1995). However, recently a number of membrane-bound 
Rab interacting proteins have been identified, including Rab5ip, a membrane-bound 
Rab5 binding protein that has an N-terminal transmembrane domain (Hoffenberg et 
al., 2000). Rip11, a RCP homologue, is also predominantly membrane-bound 
(Prekeris et al., 2000), as is the FYVE domain containing Rab4 interacting protein, 
Rabip4 (Cormont et al., 2001).   
 No putative transmembrane domains were identified in the RCP amino acid 
sequence, suggesting that it is a peripheral membrane protein. To determine the 
stability of RCP on membranes, HeLa postnuclear supernatants were treated with high 
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salt concentrations, high pH, or detergent, prior to separation into cytosolic and 
membrane fractions; 
 
 
Figure 22. Fractionation of HeLa cells. The PNS of HeLa cells were incubated with 
The majority of RCP appeared to be resistant to extraction by 1M NaCl and 
high pH
3.1.8 H13p Interacts with Rab4 and Rab11 in vitro 
The H13p interaction with Rab4 and Rab11 in the yeast two-hybrid system 
appears
high pH, 1M NaCl, or 1% TX-100 prior to separation into 100,000g pellet (P) and 
100,000g supernatant (S) fractions. The fractions were probed with affinity purified 
H13p antibody. The accuracy of the fractionation procedure was confirmed by 
probing for the TfnR (an integral membrane protein), and -actin (a cytosolic 
protein).  
 
, however, RCP was completely soluble in 1% Triton X-100. This contrasts 
somewhat with the membrane stability of Rip11. Rip11 is resistant to high salt 
concentrations, but is partially extracted by high pH, and only approximately 50% is 
extracted from the membrane by 1% TX-100.  These differences may reflect the 
different roles that these two proteins play. Unlike RCP, Rip11 displays a preference 
for GTP-bound Rab11 and Prekeris et al. suggest that Rip11 binds to the recycling 
compartment membrane via Rab11 and by interaction with neutral phospholipids.   
 
 
 to be specific, in that it does not interact with other, closely related, Rab 
GTPases. Also, the interaction with Rab4 is nucleotide-dependent. However, it is 
necessary to demonstrate the interaction in other systems. To show a direct interaction 
between H13p and Rab4, or Rab11, an in vitro overlay assay was used. GST-tagged 
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H13p was transferred to nitrocellulose and incubated with [32P]GTP-labelled Rab4 or 
Rab11. After incubation with the radioloabelled Rab protein, the nitrocellulose was 
washed and exposed on a phosphoimager; 
 
 
 
 
 
 
   
itro interaction between H13p and radiolabelled Rab4 or Rab11. 
Both Rab4 and Rab11 bound to H13p on the nitrocellulose, as indicated by a 
band a
3.1.9 RCP displays a Punctate Distribution in HeLa Cells and 
All the evidence presented so far suggests that RCP is a genuine Rab4 and 
Rab11 
     
H13p 
   
Figure 23. In v
Radiolabelled Rab5 was used as a negative control.  
 
t 37kDa. As a negative control [32P]GTP-Rab5 was used. As expected, Rab5 
did not show any interaction with H13p. These data demonstrated that the interactions 
were not an artefact of the two-hybrid system and that no accessory factors were 
necessary i.e. purified H13p can interact with purified Rab4 or Rab11.  
 
Colocalises with Rab4, Rab11, and Markers of the Recycling 
Pathway 
 
interacting protein. If this is the case, then RCP should localise to part, or all, 
of the recycling pathway in HeLa cells, since both of its Rab partners play roles in 
regulating transport along this pathway. HeLa cells were chosen for most of the cell 
culture applications since they are easy to culture, they have a well defined recycling 
pathway, they are relatively easy to transfect, and clone H13 was identified from a 
HeLa cDNA library. The transferrin receptor and its ligand, transferrin, are excellent 
markers of the recycling pathway. Iron-saturated transferrin binds to the TfnR at the 
cell surface. The Tfn/TfnR complex is internalised in clathrin-coated vesicles and 
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delivered to the early sorting endosome, where the low pH causes the dissociation of 
the iron. The Tfn/TfnR complex is then recycled back to the plasma membrane, either 
directly from the sorting endosome, or in a ‘slow’ cycle via the perinuclear recycling 
compartment. 
 
3.1.9.1 Distribution of RCP in HeLa Cells 
To determine the localisation of RCP within the cell, the affinity-purified H13 
antibod
3.1.9.2 RCP Colocalises with Rab4-GFP 
The task of colocalising RCP with Rab4 is complicated by the lack of 
availab
 
y was tested for its ability to detect the endogenous protein in HeLa cells, by 
immunofluorescence. Various dilutions of the antibody were tested and it was 
determined that a 1/100 dilution gave the best signal. RCP displays a vesicular pattern 
throughout the cytoplasm, but with a concentration of the vesicles in the perinuclear 
region. To determine if RCP colocalises with the TfnR, HeLa cells were colabelled 
with the H13p-antibody and a monoclonal TfnR antibody. The TfnR pattern in HeLa 
cells is vesicular. These vesicles appear to be either large with a globular appearance, 
or finer reminiscent of the RCP-vesicles. RCP and the TfnR colocalise in the 
perinulear region (Figure 24A). However, there are also clearly vesicles that are either 
RCP-positive or TfnR-positive. Since the TfnR is found throughout the early 
endosomal pathway, which includes the plasma membrane, CCVs, uncoated vesicles, 
the sorting endosmes, and the recycling compartment, it is possible that RCP and the 
TfnR colocalise on only one of these compartments. RCP does not colocalise with 
lysobisphosphatidic acid (LBPA), a phospholipid found in late endosomes and 
lysosomes (Figure 24D), and thus a marker of the late endocytic pathway.  
 
 
le antibodies that can detect endogenous Rab4, by immunofluorescence. To 
overcome this problem, a HeLa cell line that stably expresses Rab4WT with an 
amino-terminal green fluorescent protein (GFP) fusion was used (Bielli et al., 2001). 
GFP-Rab4WT labels large vesicles in the perinuclear area. Labelling these cells with 
H13p-antibody revealed partial colocalistion between RCP and Rab4 (Figure 24B). 
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The majority of Rab4 is found on the early sorting endosome, however, a number of 
recent reports have shown that a fraction of Rab4 overlaps with Rab11 on the 
recycling compartment (Sonnichsen et al., 2000; Trischler et al., 1999). It is possible 
that the RCP colocalisation with Rab4 is at the recycling compatment. 
 
3.1.9.3 RCP Colocalises with Rab11 
o investigate the colocalisation with respect to Rab11, an affinity-purified 
rabbit R
                                                                                                            
3.1.9.4 Summary 
A number of conclusions can be drawn from these colocalisation experiments. 
The ob
 
 
T
ab11 antibody was used, that detects the endogenous Rab11. Since the H13p-
antibody was also raised in rabbits it was necessary to express exogenous RCP and 
use a monoclonal antibody to an amino-terminal epitope. RCP was subcloned into 
the pcDNA3.1HisB vector and expressed in HeLa cells from the CMV promoter 
present on the vector. A time-course experiment showed that transfecting for between 
6 and 8 hours resulted in a RCP pattern that was similar to that of endogenous RCP. 
When RCP expressing cells were colabelled with the Rab11 antibody, extensive 
colocalisation was seen between the two proteins. In fact, when the Rab11 pattern was 
compared between cells expressing RCP, and nontransfected cells it appeared that 
Rab11 was recruited, by the recombinant protein, from the cytosol to the membranes 
(Figure 24C). In some of the transfected cells, RCP could be seen on tubular 
structures, with Rab11 also labelling these tubules. No similar recruitment of Rab4 
was seen under the same conditions.  
                                                             
 
servation that RCP only partially colocalises with the TfnR and Rab4 suggests 
that it is not found throughout the early endosomal pathway, but at a more restricted 
location along this pathway. This location is probably the recycling compartment 
since RCP shows almost total colocalisation with Rab11. However, since Rab11 has 
also been seen on the TGN it is possible that there is also some RCP on this organelle. 
It appears that RCP recruits Rab11 from the cytosol to the membrane. This may 
explain the RCP/Rab11 interaction profile from the yeast two-hybrid system. Since 
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cytosolic Rab proteins are GDP-bound, if RCP was to recruit Rab11 from the cytosol, 
it would need to have the ability to interact with the inactive conformation of Rab11. 
Since there was no similar recruitment of Rab4 seen, it can be postulated that RCP 
interacts with Rab4 that is already membrane-bound, and it serves to recruit Rab11, 
from the cytosol to the correct intracellular compartment. In this way RCP may act as 
the intermediary between Rab4-regulated transport and Rab11-regulated vesicular 
transport.   
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Figure 24. RCP localises to the receptor recycling pathway in HeLa cells. Confocal 
images of HeLa cells labelled with anti-H13 (red) and with anti-TfnR (green) (A), 
Rab4GFP (green) expressing cells labelled with anti-H13 (red) (B), RCP was 
overexpressed and detected with anti-Xpress (green) and co-labelled with anti-Rab11 
(red) (C), and anti-H13 (red) and anti-LBPA (green) (D). 
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3.1.10 Overexpression of H13p in HeLa Cells Results in the Formation 
of a Tubular FITC-Transferrin Positive Membrane Network 
 
 If RCP functions along the receptor recycling pathway then expression of 
H13p, which contains the Rab4 and Rab11 interacting domain of RCP, in cultured 
cells should have an effect on the recycling of ligands. In the following series of 
experiments, H13p, or various Rab constructs, are overexpressed in HeLa cells and 
analysed for any effect they may have on the uptake and recycling of fluorescently 
labelled iron-saturated Tfn. This technique has been used extensively to analyse 
proteins involved in endocytosis (McCaffrey et al., 2001; Stenmark et al., 1995; 
Ullrich et al., 1996; van der Sluijs et al., 2001; Vitale et al., 1998; Wilcke et al., 
2000). 
To overexpress H13p, the H13 reading frame was subcloned into the 
mammalian expression vector pcDNA3.1HisB (InVitrogen). In this vector expression 
of the insert can be driven by either a cytomegalovirus (CMV) promoter, or from a T7 
promoter. For these experiments the T7 promoter was used in conjunction with an 
attenuated form of the vaccinia virus. The virus, once infected into mammalian cells, 
expresses the T7 RNA polymerase. The advantage of this system is its ability to 
express high levels of protein in a short time (3-4 hours post-transfection). 
 
3.1.10.1 FITC-Tfn Uptake at 37oC 
 
HeLa cells, grown on glass coverslips, were infected with the modified 
vaccinia virus and then transfected with either pcDNA3.1HisB H13, or the empty 
vector as a control. The transfection was allowed to proceed for 6 hours, during which 
time high levels of H13p are expressed. After transfection the cells were allowed to 
endocytose FITC-Tfn for 45 minutes at 37oC.  The cells were immediately washed 
with ice-cold 1X PBS and fixed. Transfected cells were identified with the -H13 
antibody, or a monoclonal antibody against the amino-terminal Xpress epitope. In the 
control cells the FITC-Tfn was found in punctate vesicles throughout the cytoplasm 
(Figure 25A), with an accumulation at the perinuclear region. In cells expressing 
H13p the morphology of the Tfn compartment was dramatically changed. Instead of a 
vesicular pattern, the FITC-Tfn was found in an intricate tubular network that 
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extended from the perinuclear region (Figure 25B). Since this pattern was never seen 
in control cells the effect can be attributed to the expression of H13p. The tubules 
were seen in some cells after 4 hours, with the majority of transfected cells developing 
them after 5 to 6 hours. Since the FITC-Tfn was able to enter the cell and label these 
tubules it can be concluded that overexpression of H13p does not inhibit the uptake of 
transferrin. 
What are these tubules, and how do they develop? The recycling compartment, 
when visualised by EM and by immunofluorescent techniques, has been described as 
a tubulo-vesicular network (Sonnichsen et al., 2000; Trischler et al., 1999). It is 
possible that these H13p-induced tubules are due to an enlargement of the recycling 
compartment, as opposed to the creation of an abnormal compartment. The formation 
of these tubules may be explained in two ways; (i) overexpression of H13p results in 
an increased rate of transport into the recycling compartment, and without a 
corresponding increase in the rate of trafficking out, transport vesicles accumulate in 
the recycling compartment resulting in its enlargement, or (ii) overexpression of H13p 
results in an inhibition of trafficking from the recycling compartment back to the 
plasma membrane, or to the TGN. With transport vesicles entering the recycling 
compartment, but none exiting, the compartment grows into the tubular structure 
observed. 
An unexpected result from these experiments was observed in a small 
proportion of transfected cells. In these cells the level of H13p expression was low, 
such that the cytoplasm was not filled with the recombinant protein, yet tubule 
formation was still induced. H13p could be seen on these tubules perfectly 
colocalising with the FITC-Tfn (Figure 25C). Since H13p lacks the C2-domain of 
RCP it can be concluded that this domain is not required for the membrane 
localisation of RCP. However, the C2 domain is likely to have some role in RCP 
membrane binding, such as in the correct sub-compartment localisation of the protein 
(see Discussion), or for providing a means of regulating its membrane 
association/dissociation. The H13 reading frame does not have any hydrophobic 
regions or other known membrane binding motifs, therefore, it is possible that RCP 
localises to the membranes by binding to an integral membrane protein in conjunction 
with a direct interaction with the membrane phospholipids. It cannot be ruled out that 
RCP interacts indirectly, via Rab4 or Rab11, with the recycling compartment 
membrane. However, this is improbable since it would be unlikely that there would 
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sufficient levels of endogenous membrane-bound Rab4, or Rab11, to bind the high 
quantities of H13p expressed by the vaccinia system. The RCP amino terminus is 
likely to have a role(s) in mediating the Rab4 and/or Rab11 downstream signals, since 
its absence results in such a dramatic phenotype.  
 
3.1.10.2 FITC-Tfn Uptake at 18oC 
 
Since RCP interacts with both Rab4, a predominantly early sorting endosome 
protein, and, Rab11, a recycling compartment protein, the H13p-induced tubules may 
be the result of an enlargement of one or other of the two compartments. 
Alternatively, they may be due to the two compartments fusing together. A minor 
pool of Rab11 is also found on the TGN, however, it is unlikely that the tubules are 
part of this compartment since they are accessible to Tfn. The sorting endosome and 
the recycling compartment have been described in some cell lines as being part of a 
continuous tubular network (Sonnichsen et al., 2000). However, they can be 
distinguished in a number of ways, (i) cargo can access the sorting endosome at 18oC 
but will not progress to the recycling compartment (Wilcke et al., 2000), and (ii) EGF 
will enter the sorting endosome on its way to the lysosomes, but only a minor fraction 
will proceed along the recycling pathway. 
In order to determine the origin of the H13p-induced tubules, FITC-Tfn was 
allowed to endocytose into H13 transfected, or mock transfected, cells at 18oC. If the 
tubules are formed from the early sorting endosome then they should be accessible to 
FITC-Tfn under these conditions. Conversely, if the tubules are part of the recycling 
compartment, then the FITC-Tfn should not be able to enter them at this temperature. 
In the mock transfected cells, where uptake was performed at 18oC for 45 minutes and 
after which the cells were immediately fixed, FITC-Tfn showed a vesicular pattern in 
the periphery of the cell, with no concentration in the perinuclear region. A similar 
pattern was seen in cells expressing H13p. In these cells no FITC-Tfn was observed in 
tubular structures. However, if the FITC-Tfn was internalised at 18oC for 45 minutes 
and then chased at 37oC for 10 minutes, prior to fixation, the ligand was able to access 
the H13p-induced tubules (Figure 26). Similar results were seen in cells expressing 
Rab11S25N, which also induces tubulation of the FITC-Tfn compartment (data not 
shown). 
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Figure 25. Overexpression of H13p causes a perturbation of the transferrin 
compartment. FITC-Tfn (green) was continuously internalised at 37oC in mock 
transfected cells (A), in cells overexpressing H13p (red) (B), and cells minimally 
expressing H13p (red) (C).  
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3.1.10.3 Internalisation of Texas Red-EGF 
 
To further demonstrate that the H13p-induced tubules are derived from the 
recycling compartment, transfected cells were allowed to co-internalise FITC-Tfn and 
Texas Red (TxR)-EGF, at 37oC for 1 hour. The majority of epidermal growth factor 
(EGF) follows the late endocytic pathway (Renfrew and Hubbard, 1991). Once bound 
to its receptor at the cell surface, the complex is transported to the sorting endosomes 
in CCVs. From the sorting endosomes the EGF/EGF receptor complex is transported 
to the late endosomes and is eventually degraded in lysosomes. In cells that expressed 
H13p, Rab11S25N (Wilcke et al., 2000), or Rab4Q67L (McCaffrey et al., 2001), 
FITC-Tfn was found in the tubular structures, whereas the TxR-EGF was found in 
several large vesicular structures within the cell, where it colocalised with FITC-Tfn. 
No TxR-EGF was observed labelling the extent of the tubules (Figure 27).  
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Figure 26. FITC-Tfn does not enter H13p-induced tubules at 18oC. FITC-Tfn was 
internalised into H13p-expressing cells for 45 minutes at 18oC and either immediately 
fixed, or chased at 37oC for 10 minutes, prior to fixation. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27. EGF does not enter the H13p-induced tubules. FITC-Tfn (green) and TxR-
EGF (red) were co-internalised at 37oC for 1 hour in HeLa cells transfected with 
pcDNA3.1HisB (Mock), pcDNA3.1HisB H13 (H13), or pGEM1 Rab11S25N 
(Rab11S25N).  
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3.1.10.4 Summary 
 
A powerful technique for determining the function of a protein is to 
overexpress the protein of interest, or a mutant form, in cells and determine its effect 
on an in vivo assay. In this case H13p, a truncated mutant of RCP, was overexpressed 
in HeLa cells and tested for an effect on the intracellular transport of the fluorescently 
labelled ligands, FITC-Tfn and TxR-EGF. Transferrin follows the receptor recycling 
pathway, it enters the cell in a clathrin coated vesicle and is transported to the early 
sorting endosome. After discharging its cargo of iron it is recycled back to the plasma 
membrane, either directly from the sorting endosome, or in a ‘slow’ cycle via the 
perinuclear recycling compartment. EGF, when bound to its receptor on the cell 
surface, follows the same pathway as Tfn to the early sorting endosome. But from 
here the majority of EGF is sorted for transport along the late endocytic pathway, 
where it eventually ends up in lysosomes for degradation. Thus, these two ligands can 
be used to determine any qualitative effect H13p may have on the recycling or 
degradative pathways.  
Rab4 is located at the ‘junction’ of these pathways, the early sorting 
endosome, and plays a role in regulating transport along both of these routes 
(McCaffrey et al., 2001). Therefore, it was considered possible that RCP may have a 
role in one, or both, pathways. However, two pieces of evidence suggested RCP is 
involved only in the recycling pathway, (i) in addition to interacting with Rab4, it also 
interacts with Rab11, a recycling compartment protein, and (ii) in the cell it shows 
greater colocalisation with Rab11 than with Rab4, suggesting that it is found on the 
recycling compartment. There is only minor colocalisation with EEA1, a marker for 
the sorting endosome. It is possible RCP interacts only with the pool of Rab4 that 
travels to the recycling compartment. Since it was considered more likely that RCP 
functions along the recycling pathway, the effect of H13p-overexpression on the 
trafficking of FITC-Tfn was analysed in detail. 
H13p-overexpression results in the formation of an intricate tubular network 
that can be labelled with FITC-Tfn. To elucidate whether these tubules are derived 
from the early sorting endosomes or the recycling compartment, or are an 
amalgamation of both, two approaches were taken. The trafficking of FITC-Tfn at 
18oC revealed that the H13p-induced tubules were inaccessible to the ligand at this 
temperature (Figure 26). Transport from the sorting endosomes to the recycling 
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compartment is inhibited at 18oC (Ullrich et al., 1996; Wilcke et al., 2000). However, 
after a short chase at 37oC the FITC-Tfn was clearly found in tubules. The other 
approach was to follow the transport of EGF. The majority of EGF does not enter the 
recycling compartment but is sent along the late endocytic pathway for degradation. If 
the H13p-induced tubules were an abnormal/enlarged sorting endosome, then it would 
be likely that the TxR-EGF would label them. However, EGF was not seen in a 
tubular structure, but rather, the ligand was associated with large vesicular structures, 
overlapping, or near, the tubules (Figure 27).  
The most plausible explanation of the results presented in this section is that 
H13p, which contains the Rab4 and Rab11 binding domain of RCP, locks the two 
GTPases in a nonfunctional complex. Without the presence of the amino-terminus, 
H13p cannot perform the normal RCP function upon Rab binding. Since both 
GTPases regulate steps in the recycling pathway, transport along this pathway is 
inhibited. With transport vesicles entering the recycling compartment, but the 
downstream, Rab11-regulated, trafficking out of the recycling compartment inhibited, 
the result is the enlargement of this compartment, seen as the FITC-Tfn labelled 
tubular network. 
 
3.1.11 Expression of Active Rab11 Rescues the H13p Phenotype  
 
Rab4 and Rab11 function sequentially in the recycling pathway i.e. transport 
vesicles derived from the sorting endosome, that are destined for the ‘slow’ recycling 
pathway, are under Rab4 regulation until they are delivered to the recycling 
compartment, where they come under the control of Rab11. If RCP acts as the 
intermediary between Rab4-regulated transport vesicles and Rab11-regulated 
transport, then RCP would function downstream of Rab4 and upstream of Rab11 in 
the receptor recycling pathway. Due to the sequestration of endogenous Rab11 in an 
inactive complex, the GTPase is not able to perform its downstream function. If this is 
the case, then it would be expected that addition of Rab11WT or its constitutively 
active mutant, Rab11Q70L, to cells expressing H13p would reverse the tubulation 
(see Figure 28). To test this hypothesis, FITC-Tfn was continuously internalised at 
37oC in cells cotransfected with clone H13 and Rab11WT or Rab11Q70L. In cells 
transfected with clone H13 and the pGEM1 empty vector extensive tubulation was 
 85
observed, as expected (Figure 29A). However, in cells expressing H13p and 
Rab11WT or Rab11Q70L no tubulation was observed (Figure 29B&C). 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 28. Schematic representation of the proposed Rab4/RCP/Rab11 network, with 
the effects of H13p addition with/without active Rab11. Arrows indicate the direction 
of transport. 
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Figure 29. Active Rab11 reverses the H13p phenotype. FITC-Tfn was internalised at 
37oC in HeLa cells expressing H13p (red) alone (A), Rab11WT (cyan) and H13p 
(red) (B), or Rab11Q70L and H13p (C).  
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These results are consistent with the hypothesis that Rab11 functions 
downstream of RCP. The inhibition of recycling that results from the overexpression 
of H13p is bypassed by the addition of active Rab11, which compensates for the 
endogenous Rab11 that is sequestered in an inactive complex with H13p. This also 
explains why H13p expression gives a phenotype similar to the GDP-locked mutant 
of Rab11, since in both cases Rab11 cannot perform its downstream function.  
 
3.1.12 In Vitro Recycling Assay 
 
To quantitatively analyse the effect that overexpression of H13p, or full-length 
RCP, has on the recycling of Tfn, an in vitro assay that measures the uptake and 
recycling of 125I-Tfn was employed (these experiments were kindly performed by Dr 
Cecilia Bucci, University of Naples, Italy). BHK cells were co-transfected with 
pcDNA3.1HisB H13, or pGEM1 RCP, and a vector expressing the human TfnR. 
Expression was driven by T7 RNA polymerase from the vaccinia system. 125I-Tfn was 
bound to the surface of the cell at 4oC, excess ligand was washed off, and the bound 
Tfn was allowed to internalise. The amount of 125I-Tfn recycled out of the cell was 
measured at different time points, and compared to the amount of recycled Tfn in 
control cells, i.e. cells transfected with the human TfnR alone (Figure 30A). In cells 
expressing H13p there is almost 50% less 125I-Tfn in the culture medium at time-
points from 15 minutes on, when compared to the control cells, suggesting that H13p 
is dramatically inhibiting the recycling of Tfn. In contrast, full-length RCP appears to 
slightly stimulate recycling. The effect on recycling of dominant negative Rab4, 
Rab4S22N, was also tested and compared with that of H13p. H13p showed a more 
significant inhibition of 125I-Tfn recycling.  
Due to the localisation of RCP on the recycling compartment it was decided to 
analyse the effect that H13p, or full-length RCP, has on the rate of recycling 
specifically along the ‘slow’ pathway. To preferentially quantitate traffic through the 
recycling compartment, transfected BHK cells were pulsed with 125I-Tfn for 5 
minutes, excess ligand was washed off, and the cells were incubated for a further 30 
minutes at 37oC to allow the 125I-Tfn following the ‘fast’ pathway to chase out of the 
cell, and the Tfn trafficking along the ‘slow’ pathway to enter the recycling 
compartment. Recycling from this compartment was then measured (Ullrich et al., 
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1996). Again overexpression of H13p resulted in a strong inhibition of 125I-Tfn 
recycling. Full-length RCP stimulated recycling to a small degree, and Rab11S25N 
also inhibited recycling, but to a lesser extent than H13p (Figure 30B). 
The results from the two sets of experiments, taken together, suggest that RCP 
plays a role in regulating the ‘slow’ recycling pathway i.e. transport that passes 
through the recycling compartment. This agrees well with the observation that RCP is 
a recycling compartment protein. The stronger inhibition observed with H13p, 
compared to the dominant negative Rab11 or Rab4 mutants, may be the result of a 
cumulative inhibition due to the sequestration of both Rab4 and Rab11 in an inactive 
complex. It is also possible that RCP binds to the other members of the Rab11 family. 
KIAA0941, KIAA0665, and Rip11 all interact with Rab25, in addition to Rab11 
(Hales et al., 2001; Prekeris et al.,  2001). Similar experiments that followed the 
recycling and degradation of 125I-EGF, revealed that H13p inhibits the trafficking of 
the fraction of EGF that follows the recycling pathway, without affecting the 
degradation of the pool of EGF that follows the late endocytic pathway (data not 
shown).   
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Figure 30. Kinetic analysis of the recycling of Tfn in cells overexpressing H13, full-
length RCP, or dominant-negative Rab4 or Rab11. BHK cells were transfected with 
the human TfnR alone (control, ▅) or together with H13 (◊), full-length RCP (○), 
Rab4S22N (∆), or Rab11S25N (□). (A) Cells were allowed to bind 125I-Tfn for 1 hour 
on ice. Excess ligand was removed and cells were incubated at 37oC for the indicated 
times. (B) Recycling from the recycling compartment. Transfected BHK cells were 
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pulsed with 125I-Tfn for 5 minutes. Excess Tfn was removed, and the cells were 
incubated at 37oC for a further 30 minutes to chase the Tfn into the recycling 
compartment. Finally, the cells were washed again and incubated at 37oC for the 
indicated periods of time. (A and B) At each time-point the amount of 125I-Tfn in the 
culture medium was measured, and expressed as a percentage of the total 125I-Tfn (i.e. 
total of cell associated 125I-Tfn and 125I-Tfn in the culture medium). In each panel the 
indicated construct is compared to the control results. The experiments were repeated 
4 times and the bar is the SEM.  
   
 3.2  KIAA0941 
 
3.2.1 KIAA0941 Sequence Analysis 
 
KIAA0941 is a 511 amino acid protein, with a predicted molecular weight of 
58kDa. It was deemed to be interesting since it shares a high degree of sequence 
homology with RCP (see Figure 19). It has an amino-terminal C2-domain (residues 
17-103), and a carboxy-terminal putative coiled-coil domain; 
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Figure 31. KIAA0941 has a putative coiled-coil domain at its carboxy-terminus. The 
x-axis indicates the residue number, and the y-axis indicates the probability of 
forming a coiled-coil (0-1). 
 
This coiled-coil domain shares approximately 53% identity and 20% similarity 
with the Rab binding domain of RCP, suggesting that KIAA0941 may also interact 
with Rab4 and Rab11; 
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Figure 32. ClustalW alignment of the carboxy-termini of KIAA0941 and RCP. 
Identities are highlighted in dark grey, and similarities in light grey. 
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The KIAA0941 cDNA was requested from the Kazusa DNA Research Institute, 
Japan. The open reading frame was amplified and subcloned into the yeast two-hybrid 
‘prey’ vector, pGADGH.  
 
3.2.2 Yeast Two-Hybrid Analysis of KIAA0941/Rab Interactions 
 
The KIAA0941 prey vector was co-transformed into S.cerevisiae L40 with 
Rab4WT and its mutants, or Rab11WT and mutants. An interaction between 
KIAA0941 and any of the Rab mutants was determined by spotting transformed 
colonies onto media lacking histidine. Surprisingly, considering the degree of 
homology with RCP, there was no interaction with Rab4. However, there was a strong 
nucleotide-independent interaction with Rab11; 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
BA 
 
Figure 33. Analysis of the interaction between KIAA0941 and Rab4, or its mutants 
(A), and Rab11, or its mutants (B). An interaction is indicated by growth on media 
lacking histidine. 
 
Quantitative -galactosidase interaction assays revealed that KIAA0941 
showed no significant preference for the nucleotide-bound state of Rab11. The 
strength of the interaction with all the Rab11 mutants was considerably higher than 
the RCP/Rab11 interaction (data not shown). There was no interaction between 
KIAA0941 and any of the other Rab GTPases tested (Rabs 3,5,6, and 7), although, 
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this does not rule out the possibility that it may interact with other recycling 
compartment Rab proteins, e.g. Rab15 (not tested) (Zuk and Elferink, 1999), or Rab 
proteins localised at the plasma membrane that function to accept transport vesicles 
from the recycling compartment.  
Rip11, which also has a carboxy-terminal domain with high homology to 
RCP, also does not interact with Rab4 (unpublished results from Cell & Molecular 
Biology Lab., UCC). It is possible that Rip11 and KIAA0941 function after the Rab4-
regulated delivery of material to the pericentriolar recycling compartment. They may 
function in the next step, the Rab11-regulated transport of material through the 
recycling compartment, or transport from the recycling compartment back to the 
plasma membrane, to the TGN, or elsewhere.  
 
3.2.2.1 The Carboxy-terminal 66 amino-acids of KIAA0941 Mediate its 
Interaction with Rab11 
 
To confirm that the carboxy-terminal coiled-coil domain of KIAA0941 
mediates the interaction with Rab11, two truncation mutants were made in the 
KIAA0941 prey vector. These mutants took advantage of restriction enzyme sites 
within the KIAA0941 open reading frame. The amino-terminal mutant carried the 
first 445 amino acids of KIAA0941, but lacked the coiled-coil domain. The carboxy-
terminal truncation expressed the final 66 residues that encompassed the coiled-coil 
domain. The ability of these two mutants to activate the transcription of the HIS3 
gene was determined. From Figure 34 it can be seen that the carboxy-terminal region 
is sufficient to mediate the Rab11 interaction. This is an agreement with the results 
observed for the RCP interaction. 
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Figure 34. The carboxy-terminus of KIAA0941 mediates the interaction with Rab11. 
Full-length KIAA0941, or its truncation mutants, were co-transformed into 
S.cerevisiae L40 with Rab11WT. Interactions were detected by growth on media 
lacking histidine. Schematics represent the constructs tested. AD (Gal4 activation 
domain), RBD (Rab binding domain). 
 
3.2.3 Expression and Purification of KIAA0941 Protein 
 
The full-length KIAA0941 open reading frame was subcloned into pTrcHisC 
and expressed and purified from E.coli BL21 lysates; 
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Figure 35. Coomassie Blue gel showing the steps involved in purifying 6XHis-
KIAA0941FL.  
To reduce the likelihood that antibodies raised against KIAA0941 may detect 
RCP it was decided to use the less homologous, amino-terminal region to inoculate 
rabbits. Using a suitable restriction enzyme site (HindIII) the carboxy-terminal 235 
amino-acids were digested out of the expression vector and the backbone was 
religated. Following the purification procedure a doublet running at approximately 
40kDa was eluted from the Ni2+-agarose; 
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Figure 36. Coomassie Blue gel showing the steps involved in purifying 6XHis-
KIAA0941NTp.  
 
Immunoblotting with an anti-6XHis antibody revealed that both bands in the 
doublet carried a his-tag and both bands were expressed after induction with IPTG. 
Therefore, it is likely that the lower band is a degradation product of KIAA0941NTp. 
This preparation of KIAA0941NTp was used to inoculate a New Zealand White 
rabbit. The rabbit was given a series of 6 injections of the recombinant protein (250g 
per injection) over eight weeks. 
 The carboxy-terminal 235 amino acids of KIAA0941 (KIAA0941CTp) were 
also purified; 
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Figure 37. Coomassie Blue gel showing the steps involved in purifying 6XHis-
KIAA0941CTp.  
 
The resulting polypeptide was approximately 33kDa in size. The majority of 
KIAA0941CTp was insoluble, however, there was a significant proportion in the 
soluble fraction, which allowed low amounts of the truncation mutant to be purified. 
 
3.2.3.1 KIAA0941 Antiserum 
 
A 1 in 500 dilution of the antiserum raised against KIAA0941Ntp detected a 
strong approximately 66kDa band in 25g of HeLa postnuclear supernatant (Figure 
38). To determine whether the H13p serum cross-reacted with KIAA0941 and vice 
versa, increasing amounts of a bacterial lysate expressing full-length His-KIAA0941, 
or GST-RCP, were transferred to nitrocellulose and probed with the opposing 
antiserum. Neither antiserum showed any cross-reactivity (Figure 39).  
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Figure 38. KIAA0941 antiserum detects a 66kDa band in HeLa PNS. The amount of 
HeLa PNS loaded is indicated above each lane.  
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
Figure 39. H13p and KIAA0941Ntp antisera do not cross-react. (A) H13p antiserum 
(1:1000) does not detect His-KIAA0941FLp. GST-RCP was used as a positive 
control. (B) KIAA0941p antiserum (1:500) does not detect GST-RCP. His-
KIAA0941FLp was used as a positive control. The amounts of E.coli lysate in each 
lane are indicated above.  
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3.2.4 KIAA0941 interacts with Rab11 in vitro 
 
To determine if KIAA0941 interacts with Rab11 in vitro, and to determine if 
the interaction is a direct protein-protein interaction, a Far Western technique was 
employed. Approximately 2g of purified full-length KIAA0941p, KIAA0941NTp, 
and KIAA0941CTp were run on an SDS-PAGE gel and transferred to nitrocellulose. 
The nitrocellulose was incubated overnight in ‘Renaturation Buffer’. 10g of purified 
GST-tagged Rab11Q70L was incubated with cold GTP. The GST-Rab11Q70L was 
used to probe the nitrocellulose. Any Rab11 that was bound to the immobilised 
KIAA0941 recombinant proteins, after several wash steps, was detected with an anti-
GST antibody (Amersham Pharmacia) (Figure 40). Rab11 bound to full-length 
KIAA0941p and the carboxy-terminal fusion protein, but did not bind to the amino-
terminus of KIAA0941. This confirms the yeast two-hybrid results. 
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Figure 40. Rab11 interacts with KIAA0941 in vitro. (A) Far Western blot; bound 
Rab11 was detected with an -GST antibody. (B) Western blot; an -His antibody 
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was used to show loading of full-length KIAA0941p and its truncation mutants. H13p 
is loaded as a positive control. Schematic indicates the construct loaded in each lane. 
  
3.2.5 Green Fluorescent Protein-tagged KIAA0941 Localises to 
Vesicular Structures in the Perinuclear Region of HeLa Cells 
 
To determine the localisation of KIAA0941 within the cell, the full-length 
protein was subcloned into pEGFP-C1 (Clontech). This vector adds an enhanced 
green fluorescent protein (EGFP) fusion to the amino terminus of KIAA0941. The 
GFP tag enables the direct visualisation of KIAA0941 in HeLa cells without the 
necessity for antibody staining procedures. The construct was transfected into HeLa 
cells using Effectene (Qiagen), and after 6 hours it was possible to observe the GFP-
KIAA0941 localising to distinct vesicles around the perinuclear area of the cell 
(Figure 41A). There appeared to be very few labelled vesicular structures in the 
periphery of the cells.  
The observation that KIAA0941 interacts with Rab11, and by analogy with its 
homologue RCP it would be likely that the perinuclear vesicles labelled by the GFP 
construct are part of the recycling compartment. To confirm this, cells expressing 
GFP-KIAA0941 were labelled for the TfnR and Rab11. There was partial 
colocalisation with the TfnR (Figure 42A), and almost complete colocalisation with 
Rab11 (Figure 41A). In the Rab11 experiment, similar to the effect seen upon 
expression of RCP, Rab11 appeared to be recruited to the GFP-KIAA0941 positive 
vesicles.  
 
3.2.6 Localisation of the Amino-terminal and Carboxy-terminal 
Regions of KIAA0941 
 
To investigate the roles of the amino- and carboxy- terminal domains of 
KIAA0941, truncation mutants were constructed that expressed, either the carboxy-
terminus, pEGFP-KIAA0941Ct (amino acids 446-511), or the amino-terminus, 
pEGFP-KIAA0941Nt (amino acids 3-445), of KIAA0941 fused to GFP. The GFP-
 101
KIAA0941Nt construct contained the C2-domain, leucine-zipper, and a large part of 
the nonhomologous region that separates the two domains. The GFP-KIAA0941Ct 
mutant contained the coiled-coil Rab binding domain. Expression of the carboxy-
terminus mutant in HeLa cells resulted in a similar pattern to the full-length protein. 
The construct labelled perinuclear vesicular structures. Interestingly, in some cells 
these structures appeared to be in the process of elongating (Figures 41C & 42C). 
This phenotype is probably the early stages of the similar phenotype seen upon H13p 
overexpression. This result indicates that the carboxy-terminal 66 amino acids of 
KIAA0941 are sufficient for the membrane localisation of KIAA0941, and also for 
the recruitment of Rab11. 
It was considered likely that the C2-phospholipid binding domain of 
KIAA0941 may also have the ability to bind to membranes. However, expression of 
GFP-KIAA0941Nt resulted in a diffuse cytosolic pattern (Figures 41B & 42B). Since 
the strong cytosolic signal may have masked specific intracellular localisation of the 
truncation protein, cells transfected with GFP-KIAA0941Nt were permeablised prior 
to fixation. This washes out cytosolic protein and allows visualisation of protein that 
is anchored to a specific lipid structure. However, prepermeablised cells showed no 
KIAA0941Nt fluorescence (data not shown). To overcome any hindrance that the 
relatively large GFP tag (approximately 23kDa) may have over the normal function of 
the C2-domain, the KIAA0941Nt construct was subcloned into the pcDNA3.1HisB 
vector. This vector adds a much smaller (approximately 3kDa) epitope to the amino-
terminus of the construct. However, similar results to the GFP-KIAA0941Nt construct 
were observed (data not shown). Although it cannot be ruled out that the presence of 
any epitope disrupts the C2-domain, it appears that this domain cannot, alone, bind to 
the recycling compartment in vivo. 
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Figure 41. GFP-KIAA0941 and its truncation mutants localised with Rab11. HeLa 
cells were transfected for 6 hours with the indicated construct and labelled with anti-
Rab11 (red). Schematics represent the constructs transfected. 
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Figure 42. GFP-KIAA0941 and its truncation mutants localised with the TfnR. HeLa 
cells were transfected for 6 hours with the indicated construct and labelled with anti-
TfnR (red). Schematics represent the constructs transfected. 
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3.2.7 Internalisation of FITC-Tfn in KIAA0941 Expressing Cells 
 
To determine if the overexpression of KIAA0941 results in altered 
internalisation and recycling of FITC-Tfn in HeLa cells, the KIAA0941 open reading 
frame and its truncations were subcloned into the pcDNA3.1His vectors. The vaccinia 
system was used. In brief, HeLa cells were infected with the modified vaccinia virus, 
and transfected with the KIAA0941 constructs using the DOTAP transfection reagent. 
Ligand internalisation was performed six hours posttransfection.  
 
3.2.7.1 Continuous Internalisation of FITC-Tfn at 37oC 
 
In cells expressing the KIAA0941Ct construct, FITC-Tfn accumulated in an 
extensive tubular network (Figure 43B), similar to that seen upon H13p-
overexpression. This result was expected, and the tubules are likely to have been 
induced for similar reasons as the H13p-induced tubules i.e. it is possible that the 
KIAA0941Ct construct is sequestering endogenous Rab11 in an inactive complex, 
resulting in the inhibition of transport out of the recycling compartment. With 
transport into the recycling compartment occurring as normal, the compartment 
enlarges resulting in the formation of tubular structures.  
In cells that overexpressed the full-length KIAA0941 construct there was a 
dramatic reduction in the amount of FITC-Tfn within the cell. To determine if this 
observation is exclusive to Tfn, co-uptake experiments with TxR-EGF and FITC-Tfn 
were performed in KIAA0941FL overexpressing cells. In these cells there was also a 
reduced level of TxR-EGF, when compared with non-transfected cells (data not 
shown). This phenotype is difficult to reconcile with the known functions of Rab11 
and the localisation of KIAA0941. It is unlikely that KIAA0941 is inhibiting the 
internalisation of ligands from the plasma membrane since the protein appears to be 
localised to the recycling compartment, and Rab11 has not been implicated in the 
regulation of the early stages of endocytosis. The experimental design, i.e. continuous 
uptake of ligand, rules out the possibility that full-length KIAA0941 is stimulating 
recycling to such an extent that all of the ligand has been transported through the 
recycling pathway, and out of the cell, before the cells were fixed. One possible 
explanation is that overexpression of KIAA0941FL is toxic to the cell and that 
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endocytosis is shut down in these cells. In fact, when KIAA0941FL, or KIAA0941Nt, 
are transiently transfected and expressed from the CMV promoter for more than nine 
hours, cells start to die and after twenty-four hours the majority of the cells in the 
tissue culture plate have died.  
 
3.2.7.2 Active Rab11 Does Not Rescue the KIAA0941Ct Phenotype 
 
To determine whether KIAA0941 functions upstream or downstream of 
Rab11, the ability of Rab11 to reverse the phenotype induced by the dominant-
negative KIAA0941Ct was tested. HeLa cells were co-transfected with KIAA0941Ct 
and Rab11WT (Figure 43C), or Rab11Q70L (Figure 43D), or co-transfected with 
KIAA0941Ct and the pGEM1 empty vector (Figure 43B). Six hours post-transfection 
the cells were allowed to internalise FITC-Tfn for 45 minutes at 37oC. FITC-Tfn 
uptake in HeLa cells co-transfected with the parent vectors of the Rab11 (pGEM1) 
and KIAA0941 (pcDNA3.1HisB) constructs resulted in a pattern similar to that seen 
in non-transfected cells (Figure 43A). In cells expressing both KIAA0941Ct and 
active Rab11, a tubular phenotype was observed.  This is in contrast with the results 
observed for the H13p-induced phenotype. These results suggest that KIAA0941 
functions downstream of Rab11 in the receptor recycling pathway.  
 
 
 A 
 
 
 
 
 
 
 
 B 
C 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
D  
 
 
 
 
 
 
 
 
 
Figure 43. Active Rab11 does not rescue the KIAA0941Ct phenotype. FITC-Tfn 
(green) was internalised into cells co-transfected with pGEM1 and pcDNA3.1HisB 
(A), pGEM1 and KIAA0941Ct (red) (B), Rab11WT (cyan) and KIAA0941Ct (red) 
(C), and Rab11Q70L (cyan) and KIAA0941Ct (red) (D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 Discussion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.1 The Identification of a Novel Rab4 Interacting Protein 
 
The yeast two-hybrid technique is a powerful tool for identifying the binding 
partners of a protein of interest. It first proved invaluable for finding the downstream 
targets of small G proteins, when this method was used to identify Raf-1, a target for 
activated Ras (Vojtek et al., 1993). Since then it has been used successfully to identify 
a number of Rab interacting proteins (Bielli et al., 2001; Cormont et al., 2001; Echard 
et al., 1998; Janoueix-Lerosey et al., 1995; Nagelkerken et al., 2000; Stenmark et al., 
1995). It was decided to use the yeast two-hybrid technique to identify potential Rab4 
effectors. The strategy adopted was to use a constitutively active mutant of Rab4, 
Rab4Q67L(-CXC), as the ‘bait’ to screen a HeLa cDNA library. Two groups of 
clones were identified in this screen. The first coded for a portion of the Rab5 
effector, Rabaptin-5, a protein that had also been shown to interact with Rab4 (Vitale 
et al., 1998). The second group, which included clone H13, contained identical inserts 
coding for the carboxy-terminal 270 amino acids of a novel protein. At the time of its 
isolation, this polypeptide had no homologues in the public databases. Analysis of the 
amino acid sequence identified a potential alpha-helical coiled-coil domain.  
Further analysis of clone H13 in the two-hybrid system, demonstrated that the 
polypeptide behaved as a Rab4 effector i.e. it showed preferential binding to the GTP-
bound form of Rab4. It did not interact with a mutant locked in the GDP-bound 
conformation, Rab4S22N, and the interaction was abolished by a mutation in the 
putative effector domain of Rab4. The clone was tested for its ability to interact with 
the constitutively active forms of other Rab GTPases. It displayed no interaction with 
Rab3, Rab5, Rab6, and Rab7. This result, and the nucleotide preference of the Rab4 
interaction, suggested that clone H13 was a genuine Rab4 interacting protein and 
worth pursuing. An unexpected result was that the polypeptide displayed a strong 
interaction with Rab11, a recycling compartment Rab GTPase. This interaction was 
somewhat different than the interaction with Rab4, in that it did not appear to have a 
preference for the nucleotide-bound state of Rab11. To determine if the Rab11 
interaction could be abolished by an effector domain mutation, a constitutively active 
mutant of Rab11, with a point mutation in its effector domain, was constructed. 
However, this mutation did not abolish the interaction, although, in quantitative 
assays the interaction strength was reduced by about one quarter. It has been 
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demonstrated that Rab4 and Rab11 show a significant overlap in their intracellular 
localisation (Sonnichsen et al., 2000; Trischler et al., 1999), and since they both have 
regulatory roles in the receptor recycling pathway, it was considered possible that 
these two Rab proteins share one or more binding partners. This had already been 
demonstrated for Rab5 and Rab4, both of which interact with Rabaptin-5.  
       
4.2 RCP is a Recycling Compartment Protein 
 
The clone H13 polypeptide (H13p) was expressed in a prokaryotic expression 
system and antibodies were raised against it. These antibodies were used to probe a 
number of cell lysates. A single band migrating at approximately 80kDa was detected 
in all the lysates tested. Since the H13 polypeptide was 37kDa, the two-hybrid clone 
did not code for the entire protein. The full-length protein was named Rab Coupling 
Protein (RCP), due to the observation that it interacts with two sequentially 
functioning Rab GTPases. After a number of unsuccessful attempts to isolate the full-
length RCP cDNA, an expressed sequence tag (EST) that contained the full open 
reading frame, was deposited in the publicly available databases. The difficulty in 
cloning the 5’-end of RCP may have been due to a number of factors including the 
high GC-content at the 5’-end, and the presence of a NotI restriction site 
approximately 300bp from the initiating ATG. NotI is a restriction enzyme commonly 
used in the construction of cDNA libraries. The EST open reading frame was 
expressed in HeLa cells and the exogenous protein was shown to migrate at the same 
molecular weight as endogenous RCP. 
Fractionation of HeLa cell lysates identified RCP as a predominantly 
membrane-bound protein, however, analysis of the amino acid sequence suggested 
that the protein is predominantly hydrophilic, with no potential transmembrane 
domains. Its membrane localisation is stable under high pH and salt conditions, but it 
is completely soluble in the presence of the detergent, Triton X-100, indicating that it 
is a peripheral membrane protein. It has a C2 phospholipid-binding motif at its amino-
terminus, which may play a role in the subcellular targeting of RCP. The affinity-
purified RCP antibody gave a vesicular pattern when used to detect the endogenous 
protein, by immunofluorescence, in HeLa cells. These punctate vesicles were seen 
throughout the cytoplasm, however they appeared to be more concentrated in the 
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perinuclear region. Colabelling experiments demonstrated that RCP partially 
colocalised with the TfnR and GFP-Rab4. To colocalise with Rab11, RCP was 
overexpressed at low levels and detected with a monoclonal antibody that recognised 
an amino-terminal epitope. Rab11 was detected with a rabbit polyclonal antibody. 
Under these conditions Rab11 displayed almost complete colocalisation with RCP. 
This result was all the more striking in that the cytosolic Rab11 appeared to be 
recruited by the recombinant RCP to the membranes. Rab11 displayed a much more 
diffuse pattern in cells that were not expressing the recombinant RCP. There appeared 
to be no similar recruitment of Rab4 from the cytosol.  
To help decipher the function of RCP, the effect of the overexpression of 
H13p on the endocytic pathway was tested in HeLa cells. Fluorescently labelled Tfn 
accumulated in a complex tubular network in the cells that expressed the H13 
polypeptide. The normal wild-type pattern was observed in non-expressing cells i.e. 
the Tfn displayed a much more vesicular pattern with a concentration of the ligand in 
the perinuclear region. EGF, the majority of which does not follow the recycling 
pathway did not accumulate in these tubular structures. Quantitative assays 
demonstrated that overexpression of H13p strongly inhibited the recycling of ligands. 
An interesting observation from the immunofluorescence experiments was seen in 
some cells that were minimally overexpressing H13p. The polypeptide in these cells 
was seen labelling the tubules. This indicates that the amino-terminal C2 domain is 
not a requirement for membrane binding. Thus, the carboxy-terminus, which contains 
the Rab binding domain, has the ability to bind membranes, either directly or via 
another membrane bound protein.  
The almost complete colocalisation with Rab11, and the observation that there 
was very little overlap between RCP and EEA1, suggested that RCP is a recycling 
compartment protein. To test this further, the H13p-induced tubules were examined 
for their accessibility to internalised Tfn under different temperature conditions. When 
the fluorescent ligand was internalised at 18oC it was unable to access the tubules, 
however, if the uptake at 18oC was followed by a short chase at 37oC, then the Tfn 
could be seen labelling the tubules. Transferrin is internalised into sorting endosomes 
at 18oC, but transport out of the sorting endosome is blocked at this temperature 
(Wilcke et al., 2000). From this result, it can be concluded that the H13p-induced 
tubules are derived from the recycling compartment. Co-expression of active Rab11 
with H13p rescues the tubular phenotype.  
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4.3 RCP Belongs to a Family of Rab11 Interacting Proteins 
 
Homology searches of the GenBank databases with the RCP amino acid 
sequence revealed that it has a number of human homologues. These include 
KIAA0857, KIAA0941, KIAA0665, KIAA1821, and Rab11-FIP1. KIAA0857 has 
since been reported as pp75 (Wang et al., 1999), Rip11 (Prekeris et al., 2000), and 
Gaf-1 (Chen et al., 2001). Wang et al. reported KIAA0857 as a protein involved in 
systemic and neonatal lupus erythematosus, Prekeris et al. identified it in a screen for 
Rab11 effectors, and Chen et al. discovered it in a yeast two-hybrid screen for -
SNAP interacting proteins. KIAA0941 interacts with Rab11 in a nucleotide-
independent manner (see Results) and has since been reported as Rab11-FIP2 (Hales 
et al., 2001), and nRip11 (Prekeris et al., 2001). KIAA0665 interacts with Rab11-
GTP, and has been named Rab11-FIP3 (Hales et al., 2001), and Eferin (Prekeris et al., 
2001). Rab11-FIP1 was identified as a Rab11 interacting protein from a yeast two-
hybrid screen by Hales et al..  KIAA1821 interacts preferentially with Rab11-GTP, 
and shows no interaction with Rab4 (personal communication, Debborah Wallace). 
Thus, RCP belongs to a family of Rab11 interacting proteins, but is unique in that it is 
the only member to also interact with Rab4 (it should be noted that Rab11-FIP1 has 
not been tested for an interaction with Rab4).  
The members of this family are characterised by an -helical coiled-coil 
domain, at their carboxy-termini, which mediates their interaction with Rab11. 
Prekeris et al. have mapped the Rab binding domain (RBD) to 20 amino acids; 
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Figure 44.  (A) ClustalW alignment of the coiled-coil domains of the close RCP 
homologues. (B) ClustalW alignment including the more divergent members of the 
RCP-family, KIAA0665 and KIAA1821. The line indicates the minimal RBD 
identified by Prekeris et al..  
 
Another characteristic of this family is that they possess (with the exception of 
Rab11-FIP1) a phospholipid-binding domain. RCP, KIAA0857, and KIAA0941, 
contain a C2 domain near their amino-termini. KIAA0665 and KIAA1821 carry EF-
hand motifs (Figure 45). EF-hand motifs are generally short (approximately 30 
residues) helix-loop-helix motifs that bind calcium or magnesium. They are the most 
common calcium-binding motif in mammalian cells. Interestingly, they have been 
found in myosin, and a pair of EF-hands make up the Eps15 homology (EH) domain 
(Lewit-Bentley and Rety, 2000). EH domains have been identified in the recycling 
compartment protein Rme1 (Lin et al., 2001). KIAA0665 and KIAA1821 also possess 
ezrin/radixin/moesin (ERM) motifs just upstream of their RBD. ERM proteins are 
generally found in actin-rich cell surface structures where they function to cross-link 
actin filaments with the plasma membrane. They have been implicated in cell-cell 
adhesion, formation of microvilli, cell motility, and notably signal transduction 
pathways and membrane trafficking (Louvet-Vallee, 2000). 
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Figure 45. Schematic diagram depicting the domain organisation of RCP and its 
homologues. All names under which the individual proteins have been reported are 
indicated.  
     
4.3.1 The Significance of the Phospholipid Binding Domains 
 
It is becoming increasingly clear that a large number of effector proteins that 
are involved in endocytosis, possess phospholipid-binding domains. Such domains 
include FYVE (Fab1p, YOTB, Vac1p, and EEA1; the first four proteins in which this 
domain was found), C2, pleckstrin homology (PH), PX (or Phox), and VHS (Vps27, 
Hrs, and STAM) domains. PH- and VHS- domains can bind PtdIns3P, but not with 
the same specificity as FYVE domains (see below). The PX-domain has recently been 
demonstrated to bind products of PI-3 kinase (Cheever et al., 2001; Kanai et al., 2001; 
Xu et al., 2001). The approximately 130 residue conserved motif of the PX domain is 
found in proteins involved in cell signalling pathways, vesicular transport, and cell 
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polarity. There are at least 57 human, and 15 yeast proteins that possess PX motifs 
(Wishart et al., 2001). C2 domains are approximately 130 residue motifs that can bind 
phospholipids, and in the majority of cases this lipid binding is Ca2+-regulated. 
Multiple calcium ions can bind to C2 domains, which results in a structural 
rearrangement of the domain (Rizo and Sudhof, 1998). This is in contrast to the 
smaller EF-hand Ca2+ binding motif, which is generally a helix-turn-helix substructure 
in an -helical domain and can only bind a single Ca2+ ion. C2 domains are found in a 
wide variety of proteins involved in cell signalling and membrane trafficking 
(Nalefski and Falke, 1996). Examples of C2 domain-containing proteins involved in 
membrane trafficking include the Rab3 effector, Rabphilin-3, which possesses two C2 
domains (Shirataki et al., 1993), and the synaptotagmins, which are transmembrane 
proteins localised to synaptic vesicles and are essential for the fast Ca2+ dependent 
neurotransmitter release (Sudhof and Rizo, 1996).  
Since the identification of a FYVE domain on the Rab5 effector, EEA1, 
several other proteins involved in vesicular trafficking have been identified that 
contain these domains (Gillooly et al., 2001). FYVE domains are cysteine-rich and 
can bind two zinc ions. Their function is to bind phosphotidylinositol 3-phosphate 
(PtdIns3P) (Gaullier et al., 1998; Patki et al., 1998). PtdIns3P is synthesised by 
phosphoinositide 3-kinases (PI 3-kinases) and is found largely in the sorting 
endosome membrane, although some PtdIns3P is found in the inner membranes of 
ECV/MVBs and lysosomes. Other sorting endosome FYVE domain-containing 
proteins include Rabenosyn-5 (Nielsen et al., 2000), Rabip4 (Cormont et al., 2001), 
and Hrs (Raiborg et al., 2001b). The PI 3-kinase, hVPS34p, is recruited to the sorting 
endosome by Rab5-GTP, where it then synthesises PtdIns3P, thus facilitating the 
recruitment of FYVE proteins. While the FYVE domain specifically binds PtdIns3P, 
it is not sufficient on its own, for membrane recruitment. Rabip4 requires its FYVE 
domain and a RUN domain for correct localisation (Mari et al., 2001), while Hrs 
requires the presence of the second of its two coiled-coil domains in addition to its 
FYVE-finger (Raiborg et al., 2001b). EEA1 requires its Rab5 binding domain in 
conjunction with its FYVE finger. It can be hypothesised that the correct localisation 
of FYVE finger proteins is due to a combination of the FYVE domain and a specific 
protein-protein interaction. This may be the explanation why EEA1 is recruited 
specifically to the sorting endosome despite the fact that Rab5 is also found at the 
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plasma membrane and on CCVs (Rubino et al., 2000). Hrs, while localising to the 
sorting endosome, is found on sub-domains distinct from those containing EEA1 
(Raiborg et al., 2001a). This is not surprising since Hrs does not interact with Rab5, 
but probably interacts with another sorting endosome protein via coiled-coil domain 
two. The reason why Rabip4 is not found associated with the recycling compartment 
pool of Rab4 may be due to its greater affinity for PtdIns3P, conferred by its FYVE 
domain.  
The C2 domains of RCP, Rip11, and KIAA0941, may have a similar role in 
the specific targeting of these proteins to the recycling compartment. Prekeris et al. 
demonstrated that the C2 domain of Rip11 has an affinity for phosphotidylcholine 
(PC) and phosphotidylethanolamine (PE), but shows very little binding to PtdIns3P 
(Prekeris et al., 2000). They also demonstrated that Rip11 phospholipid binding 
required Mg2+ instead of Ca2+. If the recycling compartment membrane possesses 
PC/PE-rich domains, this would provide a mechanism for the fine subcellular 
localisation of these proteins. The EF-hands of KIAA0665 and KIAA1821 may 
mediate the binding, directly or indirectly, to a different set of phospholipids found on 
a different sub-domain of the recycling compartment, or on a different compartment 
on which Rab11 resides e.g. the TGN or the plasma membrane. In this way, these 
Rab11 interacting proteins may maintain their specific localisation thus allowing for 
distinct roles, at distinct locations, in the endocytic pathway. To confirm this 
hypothesis it will be necessary to determine whether these proteins are mislocalised if 
either the phospholipid binding domain, or the protein interaction domain, is removed 
or mutated. The expression of truncation mutants of KIAA0941 in HeLa cells has 
indicated that its carboxy-terminal 65 amino acids, containing the Rab11 binding 
domain, are an absolute requirement for membrane binding. In fact, this small domain 
has the ability itself to bind membranes. Similar observations have been made for 
RCP, in that H13p can bind the endocytic membrane. However, it has yet to be 
determined whether the lack of a C2 domain results in the mislocalisation of these 
proteins on their target compartment. 
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4.4 The Biological Role of RCP and its Homologues 
 
RCP is an 80kDa, predominantly membrane-bound, protein that interacts with 
both Rab4 and Rab11. The interaction with Rab4 is nucleotide-dependent, whereas 
RCP does not appear to have a preference for the nucleotide-bound state of Rab11. It 
is a recycling compartment protein, and overexpression of a truncated form of RCP, 
that contains the Rab binding domain, causes the recycling compartment to form an 
extensive tubular network. This tubular phenotype can be rescued by adding active 
Rab11 to the system. Quantitative transport assays have demonstrated that 
overexpression of H13p results in a strong inhibition in the recycling of ligands, 
without affecting their uptake or degradation. RCP has a phospholipid binding, C2-
domain, near its amino-terminus.   
How can these pieces of data fit together into a model to explain RCP function 
along the recycling pathway? The observation that RCP interacts with two Rab 
GTPases that function sequentially along the receptor recycling pathway suggests that 
it acts as a ‘molecular bridge’ between the transport step regulated by Rab4 and the 
step regulated by Rab11. RCP may be the ‘tethering molecule’ speculated by Zerial et 
al. to link the Rab4 and Rab11 membrane domains (Sonnichsen et al., 2000; Zerial 
and McBride, 2001). The sequential action of two GTPases was first demonstrated by 
Wickner and colleagues, using a yeast homotypic vacuole fusion assay (Eitzen et al., 
2000). The yeast Rab homologue, Ypt7p, associates with effector proteins of the 
HOPS complex (Vps proteins 11, 16, 18, 33, 39, and 41) to reversibly tether vacuoles. 
Using Gdi1p, a GDI that can extract Ypt7p from membranes, the authors 
demonstrated that Ypt7p is necessary for the docking of vacuoles. However, once 
docking has occurred, the fusion reaction becomes insensitive to Gdi1p, but remains 
sensitive to GTPS. These results suggest that Ypt7p is required for the docking step 
but not for the subsequent fusion reaction. Another GTPase is required for the fusion 
reaction since fusion is inhibited by the presence of nonhydrolysable analogues of 
GTP.  
If Rab4 and Rab11 have an analogous, sequential, role in regulating the docking 
and fusion of transport vesicles with the recycling compartment, RCP may function as 
the link between these two small GTPases. This would be consistent with the data 
accumulated to date. RCP is localised to the recycling compartment, and interacts 
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preferentially with Rab4-GTP. Therefore, it is likely that RCP acts as a target for the 
pool of active Rab4 that is present on transport vesicles destined for the recycling 
compartment. RCP may then recruit Rab11 to the site of vesicle docking, where 
Rab11 becomes activated and takes over from Rab4, to regulate the next step of the 
process. This would explain the lack of nucleotide specificity of the RCP/Rab11 
interaction, since it would be necessary for RCP to have the ability to bind to Rab11-
GDP. RCP itself, or other Rab4 and Rab11 effector proteins, may interact with 
components of the SNARE machinery, thus linking the Rab and SNARE complexes.  
This hypothesis would fit in with the model proposed by Marino Zerial that 
describes the coordination of Rab-dependent membrane tethering and docking, with 
SNARE-dependent fusion (Zerial and McBride, 2001). This model proposes that cis-
SNARE complexes are selectively incorporated into Rab domains via interactions 
with Rab effectors. Once activated by the Rab effectors, the cognate SNAREs are able 
to form a trans-SNARE complex, which then drives membrane fusion. There are a 
number of layers of regulation that may occur. One, the Sec1p family of proteins can 
regulate SNARE pairing by sequestering syntaxin molecules. Rab effectors such as 
the HOPS complex and Rabenosyn-5 have been shown to interact with Sec1p-family 
proteins (Nielsen et al., 2000). They may therefore have a role in removing the Sec1p 
block on SNARE pairing, or they may deliver Sec1p to trans-SNARE pairs, thus 
stabilising them (Figure 46A). Another mechanism of regulation may involve a series 
of interactions that have been observed between Rab effectors and the SNARE 
priming machinery. The assembly of the EEA1 and Rabaptin-5/Rabex-5 oligomers, 
on the sorting endosome, is regulated by the ATPase activity of NSF. NSF in complex 
with-SNAP binds to docked SNARE complexes and promotes fusion (McBride et 
al., 1999). The presence of NSF within the Rab effector oligomer complexes could 
function to site-specifically prime SNAREs, or to regulate the interactions between 
SNAREs and Rab effectors. Another SNARE priming protein, -SNAP, a relative of 
-SNAP, has been shown to interact with Rip11 (Chen et al., 2001). (Figure 46B). 
Finally, Rab effectors have been shown to interact directly with SNAREs. For 
instance, EEA1 binds to syntaxin 13 (McBride et al., 1999), and the HOPS complex 
of Ypt7p has been found associated with the Vam3p SNARE complex (Figure 46C). 
Rab4 interacts directly with the plasma membrane t-SNARE, syntaxin 4 (Li et al., 
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2001). It will be necessary to determine if RCP interacts directly, or indirectly, with 
components of the SNARE machinery, before it can be placed in this model.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 46. Molecular interactions showing coordination between the Rab and 
SNARE machineries (Zerial and McBride, 2001).  
 
The above model for RCP function is speculative and, therefore, it cannot be 
ruled out that RCP plays no part in the docking/fusion process, or that it has other 
roles in conjunction with a role in docking/fusion. One such role could be in 
mediating vesicle motility. Rab4 interacts with the dynein light intermediate chain-1 
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subunit of the dynein motor protein, and is thought to mediate the retrograde 
cytoskeletal transport of Rab4-positive vesicles (Bielli et al., 2001). The 
unconventional myosin, myosin Vb, has been found to interact with Rab11 (Lapierre 
et al., 2001). The class V unconventional myosins have been implicated in the 
regulation of vesicle trafficking, and recent work has reported a stoichiometry of 100 
myosin Va molecules per brain vesicle. Therefore, it has been proposed that myosin 
Vb, via its interaction with Rab11, is involved in exit from the recycling system. 
Recently it has been shown that myosin Vb also interacts with KIAA0941, thus there 
is a direct, and an indirect link, between this motor protein and Rab11 (Hales et al., 
2001). Rab4 interacts directly with the light-intermediate chain 1 subunit of the 
dynein complex, however RCP does not interact with the dynein LIC1, or a partial 
clone, in the yeast two-hybrid system (unpublished data). An interaction with mysoin 
Vb has not been tested.    
RCP has a number of potential phosphorylation sites, which may provide a 
means for regulating its function. Prekeris et al. have shown that phosphorylation 
plays a role in regulating the subcellular localisation of Rip11 (Prekeris et al., 2000). 
Kinase inhibitors stabilise Rip11 on the membrane, and result in the redistribution of a 
large proportion of Rip11 to the plasma membrane. Conversely, treatment with 
phosphatase inhibitors results in the solublisation of Rip11. The authors propose the 
following model for Rip11 function:- Rip11 is recruited to the recycling compartment 
by Rab11-GTP, after budding of Rab11/Rip11 vesicles, Rip11 mediates their 
transport to the plasma membrane where it binds an unknown receptor, thus 
facilitating the pairing of cognate SNAREs, and subsequent membrane fusion. 
Hydrolysis of Rab11-GTP to GDP, and phosphorylation of Rip11, results in the 
redistribution of Rip11 from the plasma membrane to the cytoplasm, where it is free 
to return to the recycling compartment, after dephosphorylation, and enter another 
round of membrane trafficking. Whether RCP undergoes phosphorylation, and if so, 
does this result in relocalisation, is currently under investigation. The identification of 
the kinase involved would indicate the type of regulation exerted on RCP i.e. whether 
it can be regulated by extracellular signals, and/or by the cell cycle.  
What roles do the other members of the RCP family play in Rab11 regulated 
transport? In addition to the recycling compartment, Rab11 has also been observed on 
the TGN and post Golgi vesicles (Urbe et al., 1993). It can be postulated that if Rab11 
is involved in regulating transport to, or from, these compartments, as well as to the 
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plasma membrane, then distinct Rab11 effector proteins are likely to be required for 
each of these pathways. The RCP family members may function as these effectors. 
RCP is involved in the early sorting endosome to recycling compartment pathway. 
Prekeris et al. have proposed that Rip11 is involved in transport from the apical 
recycling compartment to the apical plasma membrane in polarised cells, and 
presumably from the recycling compartment to the plasma membrane in non-
polarised cells. The tubular phenotype observed upon overexpression of the Rab 
binding domain of KIAA0941, cannot be rescued by active Rab11, suggesting that it 
functions in a transport step downstream of RCP. Therefore, KIAA0941 may function 
in regulating transport through the recycling compartment, after which Rip11 takes 
over to regulate transport out of this compartment to the plasma membrane. Since 
KIAA0665 and KIAA1821 have a more divergent domain structure they may function 
to regulate transport to a different compartment, such as the TGN.  
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RCP 
 Rab11-FIP1(?) 
 KIAA0941(?) Rip11 Recycling 
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Figure 47. Schematic of the recycling pathway indicating the putative localisation of 
the RCP family members. Blue arrows indicate transport steps. 
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In a manner reminiscent of Rab5, it is emerging that both Rab4 and Rab11 
interact with multiple effectors. It is likely that there are many more that remain to be 
reported. To obtain a more comprehensive understanding of the roles of Rab4 and 
Rab11 in endocytosis, it will be necessary to identify their complete repertoire of 
interacting proteins, and to determine the precise tasks that these effectors perform 
along the Rab4 and Rab11 pathways.    
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5 Conclusion 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The yeast two-hybrid technique has allowed the identification of a novel Rab4 
and Rab11 interacting protein. This 80kDa protein was named Rab Coupling Protein 
(RCP), due to the fact that it appears to couple the function of two sequentially acting 
Rab GTPases. It shows a preference for the GTP-bound form of Rab4, however, it 
interacts strongly with both GTP- and GDP-locked Rab11. RCP is a peripheral 
membrane-bound protein localised to the recycling compartment. Overexpression of a 
truncation mutant of RCP results in a dramatic alteration in the morphology of the 
recycling compartment and an inhibition in the rate of ligand recycling. The tubular 
phenotype induced by the truncation mutant can be rescued by active Rab11, but not 
by Rab4. It can be postulated that RCP acts as the recycling compartment acceptor for 
Rab4-GTP transport vesicles en route from the early sorting endosome, and that it 
recruits Rab11 (either from the cytosol, or the recycling compartment membrane) to 
the location where these transport vesicles dock/fuse with the recycling compartment. 
Rab11 is then in a position to take over the regulation of the transport of cargo 
contained within these transport vesicles.  
Homology searches of the GenBank databases with the RCP amino acid 
sequence identified a number of close human homologues, which make up a protein 
family. The members of this RCP-family are characterised by an -helical coiled-coil 
domain at their carboxy-terminus, and either a phospholipid binding C2-domain near 
their amino-termini, or a calcium-binding EF-hand motif. Analysis of these 
homologues has demonstrated that they all interact with Rab11, but RCP is unique in 
that it is the only member tested that also interacts with Rab4. These family members 
show no significant homology with either Rabphilin-11 or Myosin Vb, two other 
Rab11 interacting proteins. The RCP homologues are each likely to function in 
distinct transport steps regulated by Rab11. 
Future work will be required to dissect the precise subcellular localisation of 
the RCP-family members to determine whether they localise to separate subdomains 
of the recycling compartment, or whether the more divergent members localise to a 
different compartment. It is likely that the C2- and EF-hand domains are involved in 
‘fine-tuning’ this localisation, therefore it will be necessary to determine the specific 
phospholipids to which they bind. An important question remaining concerning RCP 
is whether Rab4 and Rab11 can bind simultaneously to the same molecule, or whether 
they share a binding motif on RCP, and therefore the presence of one GTPase would 
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exclude the binding of the other. To further characterise the RCP-family proteins it 
will be crucial to identify the proteins through which they mediate their downstream 
functions.  
In conclusion, the identification of RCP and its homologues has added further 
data to the picture that is emerging concerning the biological roles of Rab4 and Rab11 
along the recycling pathway, and as is the case with the rapidly progressing life 
sciences, it has opened up more avenues of research that need to be explored.   
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